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1 Introduction and aim of the work 
 
A better understanding of the barrier function of the skin is relevant to a 
wide range of applications including, in particular, transdermal delivery of 
drugs and risk assessment of hazardous exposure to chemicals. The 
regulation of transdermal permeation is generally ascribed to the stratum 
corneum (SC), the outer layer of the skin [1]. 
   
The macroscopic structure of the stratum corneum was initially described 
according to the bricks and mortar model proposed by Michaels [2], where 
corneocytes are arranged like bricks in a lipid phase (the mortar phase), 
arranged in multilayers [3]. The lipids are predominantly in a continuous gel 
phase with fluid regions [4], organized in an orthorhombic conformation at 
low temperature, and undergoing a phase transition to hexagonal 
conformation at about 60 °C [5]. At the molecular level, the major 
components of the SC lipid matrix are ceramides (CER), free fatty acids 
(FFA) - ceramide 2 and FFA 24:0 being the most abundant - and cholesterol 
(CHOL) in a 1:1:1 molar ratio [6]. Selective inhibition of any one of these 
components is sufficient to compromise the barrier function of the skin [7].  
 
Potts & Guy logKp(cm/s) = 0.71 log Ko/w – 0.0061 MW – 6.3 r2 = 0.676 
Mitragotri Kp(cm/s) = 5.6 10-6 Ko/w · exp(-0.46 MR2) r2 = 0.698 
 
Table 1-1. Predictive equations for skin permeability. Kp = permeability coefficient 
expressed in cm/s; Ko/w = octanol/water partition coefficient; MW = molecular weight; MR = 
molecular radius; r2 = square of the correlation coefficient calculated on Flynn's set. 
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A large number of permeability studies have appeared in the last 60 
years, addressing the prediction of skin permeability with mathematical 
models, in particular semi-empirical or mechanistic models, the most cited of 
which being the equations by Potts and Guy [8] and Mitragotri [9], 
respectively (Table 1-1). The correlation were focused on “Flynn’s set”, a set 
of 97 molecules of known Kp [10]. 
  
Although the discovery of the link between physicochemical properties 
of a given permeant and its ability to permeate the skin can be traced back to 
the works of Stephen Rothman in the 1930s and 1940s [11], the first modern 
mathematical models of percutaneous absorption were derived by Higuchi, in 
the 1960s. In his works, the Author describes the rate of release of 
transdermal drugs in terms of drug concentrations and diffusion coefficients 
according to Fick’s first law [12][13], laying the foundation of steady-state 
(time independent) models of skin permeability. 
 
Assuming that the skin barrier is a homogenous membrane, and defining 
the permeability coefficient Kp as the steady state flux across the skin (Jss) 
divided by the concentration gradient across the skin (∆C), Fick's first law 
may be expressed as [14]: 
   
h
KD
C
JKp ss =
∆
=    Equation 1-1 
 
where D is the solute's diffusion coefficient, K its partition coefficient 
between the vehicle and the skin, and h the skin thickness. 
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Equation 1-1 is expressed for the entire skin, but different degrees of 
simplification are possible. In principle, a mathematical model of skin 
permeability should consider the contribution of the various physiological 
regions: the stratum corneum, the viable epidermis, the dermis and 
appendages, such as hair follicles and glands. Appendages are a possible 
pathway for hydrophilic solutes, but it is unlikely that they may explain their 
transdermal transport [15], and are often ignored. The overall Kp could then 
be seen as deriving from the three different contribution in series, as proposed 
by Scheuplein and Blank [16][17]: 
 
derpvepscpskinp KKKK ....
1111
++=  
 
where Kp.skin, Kp.sc, Kp.ve, Kp.der are the permeability coefficients of the 
skin, stratum corneum, viable epidermis and dermis respectively.  
 
In most works, the SC is considered the rate limiting barrier [15], even 
though focusing on the SC barrier only leads to unrealistic values of Kp for 
extremely lipophilic compounds, the percutaneous absorption of which is 
controlled by the hydrophilic viable epidermis [2].  
  
Equation 1-1 may be seen as the basis for the development of the semi-
empirical model proposed by Potts and Guy. Express the skin/vehicle 
partition coefficient K as a function of the octanol/water partition coefficient 
P [18]:  
 
bPK =  
 
 12 
where b varies from about 0.4 to 0.9. Express the diffusion coefficient D 
as a function of molecular volume MV [8]:  
 
MVeDD ⋅−= β0  
 
where 0D  and β are constants. Then, approximating the molecular 
volume MV of the permeant by its molecular weight MW, Equation 1-1, 
expressed as a logarithm, takes the form [10]: 
 
0.0061MW0.71logP6.3logK p −+−=  
 
where Kp is expressed in cm/s and the coefficients are obtained through 
linear regression of Flynn's data set excluding three compounds [10]. Since 
hydrophilic solutes are under-represented in Flynn's set, this model fail to 
provide satisfactory predictions for the Kp of hydrophilic solutes [19]. A 
thorough evaluation of semi-empirical methods is found in the review by 
Lian [1].  
  
An example of (steady-state) mechanistic model is the equation proposed 
by Mitragotri [9], based on Scaled Particle Theory, in which the partition and 
diffusion coefficients in the SC are calculated from the work required to form 
cavities in the SC, with the assumption that the solute moves in a stationary 
frame of lipids [9].  
 
Diffusion across a non-homogeneous, anisotropic medium like the SC is 
a function of its position inside the membrane, at least in the transversal 
direction (depth z), lateral (perpendicular to z direction) and transverse 
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components of the diffusion coefficient are also expected to be different, as 
an effect of anisotropy. Accounting for the anisotropy of the SC and for the 
average direction of diffusion, Scaled Particle Theory yields an average 
diffusion coefficient D [9]: 
 
2
0
rAeDD ⋅−=  
 
where r is solute molecular radius and A is a constant calculated to be ~ 
0.4 for a dipalmitoylphosphatidylcholine (DPPC) bilayer [9]. The Mitragotri 
equation then takes the form [9]: 
 
246.07.06106.5 rp ePK −−×=  
 
with the same notation as above. If MW1/3 is used as an estimation for r, 
once the Mitragotri equation is put in logarithm form it may seem similar to 
the Potts and Guy equation. However, the numerical values are derived from 
the theory employed and not from linear regression.  
 
A deeper insight on mathematical models as well as an account of other 
model based methods for the estimation of SC diffusion coefficients are 
provided in recent reviews [15][20][21]. In particular, the work by Mitragotri 
and colleagues [15] contains a thorough discussion on the theoretical 
estimation of partition and diffusion coefficients. The estimation of partition 
and diffusion coefficients may also be achieved through Molecular Dynamics 
(MD) simulations. 
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Both empirical and mechanistic models require a method of estimating 
essential parameters, such as diffusion and partition coefficients, which can 
be determined experimentally, theoretically or through computer simulations, 
in particular Molecular Dynamics simulations which are gaining increasing 
attention as a tool in skin permeability studies. Since even the longest MD 
simulations are still orders of magnitude shorter than the time scales of 
complex biological events, such as permeation [22], the data gathered from 
them as to be interpreted on the basis theoretical skin permeability models. 
 
Molecular Dynamics can be a useful tool to perform permeability 
studies, with the added benefit of a greater understanding of the permeation 
process at a molecular level, and of the role of different part of the SC in 
determining permeability. Since the time scales of MD simulations are still 
orders of magnitude lower than the time scales of the most complex 
biological events, the atomistic details obtained with simulations have to be 
included in the framework of macroscopic mathematical models [22].  
 
The use of MD simulations to study solute diffusion through lipid bilayer 
membranes was developed in the 1990s for phospholipid bilayers, starting 
with early studies on passive diffusion [23][24][25] to systematic studies of 
permeation by Marrink and Berendsen, which took into account diffusion and 
solubility of penetrants into the membrane [26][27], and extended to the 
study of SC permeation by Das and colleagues [7][28]. The approach used 
here, though, differs from that of the previous works. To allow for the 
screening of more than 80 molecules, a more indirect method has been 
attempted, not contemplating free energy calculations. Instead, only the 
diffusion coefficient and the conformational space explored by the solute in 
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the different microenvironments inside the SC have been directly derived 
from the MD simulations. All the other relevant parameters were estimated 
from those data. 
  
This work focuses on the role of Molecular Dynamics, as a tool in skin 
permeability studies. In Chapter 2, an outline of Molecular Dynamics is 
given. In Chapter 3, we look at structural MD studies on lipid matrices, and 
we analyze how the methods based on MD simulations, developed for 
phospholipid bilayers, have been applied to estimate the permeability, 
diffusion and partition coefficients in the Stratum Corneum.  Chapter 4 is 
about the computational details. The set-up of the lipid matrix model and the 
set of permeants is described, along with the simulation parameters and a 
description of production runs. Chapter 5 contains the theoretical background 
to the molecular properties and physical quantities discussed in Chapter 6. In 
Chapter 6, the results from Steered Molecular Dynamics (SMD) simulations 
are given. The goal was to investigate the dynamic behaviour of a permeant 
when crossing an ideal SC lipid matrix composed by a heterogeneous mixture 
of long-chain ceramides (CERs), free fatty acids (FFAs), and cholesterol 
(CHOL) in a 1:1:1 molar ratio. The data derived from the simulations are 
correlated to the experimental permeation coefficients contained in the 
reduced set (the intersection of Flynn's and the Fully Validated set by 
Vecchia and Bunge [81]), yielding encouraging predictive models which 
confirm the fruitfulness of MD simulations to analyze complex systems such 
as the SC at a molecular level.  
 16 
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2 Molecular Dynamics 
 
Molecules possess several degrees of freedom (vibrational, rotational, 
etc.) which allow their existence in different conformational states. 
Conformational states dynamically evolve in time, forming the so-called 
conformational space of the molecule. The molecule exploring a 
conformational space is not limited only to the lowest energy conformations, 
but it can move among different equilibrium states, which are related to the 
kinetic energy of the atoms and so to the temperature of the system. The path 
followed in conformational space depend on inter-and intra-molecular 
interactions, which depend largely on the dynamic behaviour of atoms and on 
experimental conditions.  
 
Molecular Dynamics  is a computational technique that allows to follow 
the evolution of a chemical system (a group of atoms or a group of 
molecules) using theoretic physics methods of different sophistication, from 
ab-initio or semi-empirical quantum chemistry methods to Molecular 
Mechanics (also called force-field methods) [29]. This chapter explores the 
theory behind MD, in particular classical MD which is the most relevant for 
our study. 
 
Molecular Dynamics is based on Newton's equation of motion, applied to 
the movement of particles. In the Molecular Mechanics (MM) approximation, 
MD simulations are described by deterministic classical physics, since the 
evolution of the system is determined by a set of initial conditions 
(coordinates of the particles, and the forces acting upon them). Modern MD, 
though, can take a stochastic approach, by the insertion of random forces 
along the ones described by Newton's equation.  
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2.1 Molecular Mechanics 
 
In the MM approximation, it is understated that cumulative forces can be 
used to describe molecular geometries and energies [30]. A molecule is 
considered as a set of balls (atoms) and springs (bond) the conformation of 
which is determined by the force acting on any atom, calculated as the 
cumulative effect of bonded and non-bonded interactions. 
 
 
In MM a potential energy hypersurface is constructed from a set of 
experimental data (e.g. crystal structure geometries, IR and Raman 
spectroscopy, heats of formation) and more recently even from quantum 
mechanical calculations. The functional form and the sets of parameters 
derived from experimental data used to calculate the potential energy U(r1, r2, 
...rn) as a function of atomic spatial coordinates form the so-called force-field.  
 
In the case of an isolated system composed of n particles, the force 
acting on the ith particle is related to the system's potential energy by the 
following equation: 
 
( )[ ]n212i
2
ii ,...rr,rUdt
rd
mF −∇==  Equation 2-1 
 
 where mi and ri are the mass and position of the ith particle, 
respectively and U is the potential energy and ∇ is the gradient mathematical 
operator. From this equation, the position of any atom can be determined and, 
and so its speed and acceleration. Knowledge of the potential energy function 
U, determined from the position of each particle, allows to calculate the force 
acting on each particle at any given time step (time is discretized). In turn, the 
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force so calculated is used to determine the particle's position at the 
subsequent time step, and so on to the end of the simulated time period.  
 
A fundamental assumption of MM is that the potential energy of a 
system can be expressed as the sum of the potential energy terms deriving 
from simple interactions, usually divided in bonded and non-bonded 
interactions. 
 
2.1.1 Bonded interactions 
 
Potential energy terms derived from bonded interactions include: bond 
length potential, bond angle potential and torsional potential (note that the 
term 'potential' is improperly used here to designate a potential energy 
function). 
 
The bond length potential rU  can be described by the harmonic 
potential, which is adequate for small deviation from reference values: 
 
2)()( rrSrU hharmonic −=  
 
where r  is the bond length, r is the reference value, Sh is a constant 
related to the spring constant; or by the Morse potential, valid for greater 
bond deformations: 
 
2)]}(exp[1{)( rrSDrU MMorse −−=  
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where SM and D represent the potential energy well width and depth (i.e. 
the dissociation energy), respectively. Opposite to the harmonic potential, the 
Morse potential has correct asymptotic behaviour:  DrU Morse →)( as ∞→r  
and ∞→)(rUMorse  as 0→r .  
 
Other potential forms exist, which take into consideration cubic and 
quartic terms. Bond length reference values are derived from X-ray crystal 
structures (which yield average values) or ab-initio quantum chemical 
methods (which yield equilibrium values), such as Hartree-Fock/Self 
Consistent Field.  
 
The bond angle potential θU is usually described by a harmonic 
potential: 
 
2)()( θθθ −= hharmonic KU  
 
or by a trigonometric potential 
 
2)cos(cos)( θθθ −= trictrigonomet KU  
 
where θ is the bond angle, θ  is the reference value for the bond angle, 
Kh and Kt are constants. The trigonometric potential has the advantage of 
being bounded and easier to implement (e.g. easier to differentiate) [30]. 
 
The torsional potential ϕU is modelled by a simple periodic function: 
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)]cos(1[)( ϕϕ nVU torsional −=  
 
where φ is the torsion angle, n is an integer denoting the periodicity of 
the torsional barrier and V is a constant dependent on the barrier height. 
 
The potential energy for bonded interactions can then be expressed as: 
 
∑∑∑ ++=
torsionsanglesbonds
rbonded UUUU ϕθ  
 
2.1.2 Non-bonded interactions 
 
Potential energy terms derived from bonded interactions include the 
Lennard-Jones potential and the Coulomb potential. 
 
In MD, 6-12 Lennard Jones potential is generally used to model 
cohesive van der Waals interactions, whit the addition of a short range 
repulsive term. For a pair of atoms at distance r, it takes the form: 
 














−





=
612
)(
rr
rULJ
σσ
αε  
 
where α is an adimensional constant, ε is the depth of the potential well, 
σ is the distance at which the inter-particle potential is zero. The negative 
term in the expression above, corresponds to the attractive van der Waals 
interaction, which arises from the interaction between spontaneously 
oscillating electric dipole, and it can only be explained with Quantum 
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Mechanics  [31]. The positive (repulsive) term acts at very short distances, 
originating from Pauli's exclusion principle.  
 
The Coulomb potential is used to describe ionic interactions between 
fully or partially charged particles. For an atom pair {i,j} at distance r, it takes 
the form: 
 
r
qq
KU jiCoulombCoulomb
⋅
=
ε
 
 
where qi is the electric charge on atom i, ε is the dielectric constant and 
04/1 piε=CoulombK  (ε0 being the permittivity of a vacuum). 
 
The potential energy for non-bonded interactions can then be expressed 
as: 
 
∑∑ +=−
pairsatom
Coulomb
pairsatom
LJbondednon UUU
__
 
 
2.2 Integration of the equations of motion: the Verlet 
algorithm 
 
The commonly used methods for integrating Equation 2-1 with respect to 
time belong to the Stőrmer/Verlet/leapfrog class of algorithms. These 
methods, with respect to other integration methods, such as Runge-Kutta 
have the advantage of stability and they are symplectic integrators. 
Symplectic integrators have the property of "almost" preserving the value of 
the Hamiltonian, i.e.  energy (the total energy is not preserved exactly). This 
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naturally lends to the study of the microcanonical or (NVE) ensemble, in 
which the total number of particles, N, the volume V and the total energy, E 
are held constant. If instead the canonical or (NVT) ensemble, where 
Temperature T, and not energy is constant, is to be studied, either the Verlet 
algorithm must be modified to include a thermostat, such as Nosė-Hoover 
thermostat, or Langevin's equation, instead of Newton's, must be used. 
 
The integration is achieved with a discretization of time in timesteps ∆t. 
Then, the continuous variables x(t) and v(t), position and velocity at time t 
respectively, are approximated by values at time intervals n∆t, where n is a 
positive integer. We only describe here a common variation of the Verlet 
algorithm, known as the leapfrog algorithm, so called because the velocity is 
defined a half steps 





+
2
∆t
tv  while the position is defined at whole steps 
( )∆ttx + . For a particle of mass m, on which a cumulative force F is acting, 
the velocity update is 
 
∆t
m
F
2
∆t
tv
2
∆t
tv +





−=





+  
 
and the position update is: 
 
( ) ∆t
m
F
2
∆t
tvx(t)∆ttx +





−+=+  
 
In this equation, it is assumed that the acceleration F/m is constant during 
the timestep ∆t, which must then assume very small values, which translated 
to timestep of 1 fs (femtosecond) for most systems. Indeed, the time step is 
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set around a value between 1/100 and 1/20 of the fastest period of oscillation 
of the system simulated. The optimal value is in the range of 0.2 fs 
(femtosecond), although the use of special algorithms (e.g. SHAKE) slow 
down the transitions, allowing longer time steps (1-2 fs). Since Equation 2-2 
is applied recursively,  the use of too large time steps (> 10 fs) can introduce 
recursive errors in the evaluation of the energy of the system and prevents a 
correct evaluation of the forces and accelerations. In this way, all non-linear 
energy terms are not properly estimated and consequently the system 
gradually acquires energy until its explosion. 
 
2.2.1 Constraints dynamics 
 
In the MD simulations, it is sometimes necessary to apply constraints 
that restrict the degrees of freedom of the system. Usually some torsion 
angles or atom position are restricted, for example to exploit data coming 
from NMR or X-ray studies. One of the methods employed is named SHAKE 
that tethers the distance between pairs of atoms: 
 
0dr 2ij2ij =−  
 
 where the term rij represents the instantaneous separation between two 
atoms (i and j) and dij is the reference value of the constraint. In SHAKE 
dynamics, the energy function includes a loop-free constraint, and then a 
displacement vector is added to satisfy the constraints imposed to the system. 
The position of the i-th atom at time t + dt is:  
 
( ) ( ) ( )t∆r∆ttr∆ttr i'ii ++=+  
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 where r’i (t + dt) is the position vector of the ith atom after an iteration 
without constraints, while ∆ri(t) is the displacement that satisfies the 
constraint calculates as: 
 
( ) ( )∑=
j
ijij
i
2
i trλ
m
∆t2(t)∆r  
 
 where the λij are Lagrange multipliers. 
 
Another type of constraint commonly used in MD simulations of 
biomacromolecules (nucleic acids and proteins), which allows the study of 
experimentally resolved structures, is the atom fixing. It consists in blocking 
the coordinates of a subset of atoms to avoid excessive changes in the 
experimentally validated structure. This approach, however, induces strong 
energy gradients around the fixed atoms so, other kind of atomic constraints 
are usually preferred, such as harmonic constraints, where atoms are not 
fixed, but harmonically constrained to fixed points. A recent development is 
this technique is Steered Molecular Dynamics (SMD), in which the center of 
mass of a group of atoms is harmonically constrained to a moving point. 
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2.3 Choice and importance of simulation parameters 
 
The choice of simulation parameters is a fundamental step to obtain 
reliable results. It is generally impossible to determine a priori which 
conditions are the best ones to simulate the behaviour of a given system 
properly, so different combinations of parameters should be tried in order to 
select the best conditions, evaluating all the possible situations, taking into 
consideration the available computational power.  
 
It is important to analyze the main parameters required by each program 
for molecular dynamics and their influence on the evolving simulation 
besides the required computational time. We briefly discuss temperature. 
 
2.3.1 Temperature 
 
Usually, MD simulations are performed at an absolute temperature 
between 300 and 310 K, as these are the temperatures of experimental assays 
on biological matrices. More problematic is the choice of the conditions with 
which the system is brought to the desired temperature: at the beginning, the 
atoms are stationary, then normally distributed pseudo-random velocities are 
assigned to them.  The average value Ek of the kinetic energy is related to the 
temperature of the system T as: 
 
22
1 3
1
2 TkNvmE bF
N
i
iik == ∑
=
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where NF are the degrees of freedom of the system (3N or 3N-3) and kb is 
Boltzmann's constant. 
 
So if we assign to a "cold" system at the beginning of the simulation a 
temperature of 300 K this can lead to excessively high velocities that can 
make the integration algorithm unstable. For a correct simulation at constant 
temperature heating, from 0 K to the target temperature is so required. This 
period simulates the transfer of energy from the environment to the system, 
allowing atoms to accelerate, and, only from a certain step onwards, the 
temperature is kept constant. Once the system has been heated to the desired 
temperature, it undergoes an equilibration phase, to allow for the 
redistribution of the energy in order to stabilize the global structure. To 
simulate the system under thermostatic conditions, the energy is exchanged 
with the external environment, such as an external heat bath at constant 
temperature, for the duration of the calculation.  
 
2.4 Stochastic Dynamics: fluctuation-dissipation 
relations and Langevin dynamics 
 
In a deterministic system, described by Newton's equation of motion: 
 
( )[ ]n212i
2
ii ,...rr,rUdt
rd
mF −∇==  
 
a time reversal of all the variables, at the end of a time period leads to the 
observation of the reverse trajectory in the same time period. The fact that 
Newton's equation of motion is time reversal symmetric is in contrast with 
the common experience that all but the simplest processes are irreversible. 
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This irreversibility is linked to a quantity that always grows in the universe, 
entropy, which has been given different explanations in the past, for example 
by Boltzmann and Gibbs. A more modern view is that Newton's equation of 
motion is capable of explaining irreversibility, if it's complemented by the 
acceptance of uncertainty in the way systems behave, due to interactions with 
the environment. So modified, Newton's equation leads to a quantity that 
always grows with time, like Entropy, and that's uncertainty itself. When this 
uncertainty is added to Newton's equation of motion, symmetry is broken, 
and the deterministic laws of evolution of the system must be replaced by 
rules for the evolution of the probability that the system takes a certain 
configuration [32].  Such rules define a stochastic process. A general 
equation describing the evolution of probability density functions P which 
are continuous in space and in time, is the Fokker-Plank equation (FPE): 
 
2
2
2
1 )),(),((
2
1),(),((),(
x
txPtxM
x
txPtxM
t
txP
∂
∂
+
∂
∂
−=
∂
∂
 
 
where M1 and M2 are the first and second Kramers-Moyal coefficients 
(we omit their definition).  
 
If Newton's equation is supplemented with environmental forces, of 
which some are random, we obtain an equation describing a stochastic 
process, such as Langevin equation, which describes the evolution of the 
velocity v of a particle. The Langevin equation can be put in the form: 
 
)(tbvv ξγ +−=&  Equation 2-2 
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where γ is the damping coefficient, b is a constant, ξ(t) has the property 
0)( =tξ  and it has no autocorrelation in time. It can be shown [32] that 
Equation 2-2 is equivalent to the FPE is we take vM γ−=1  and 22 bM = . 
The FPE equivalent of Langevin equation is: 
 
2
22 ),(
2
),((),(
v
tvPb
v
tvvP
t
tvP
∂
∂
+
∂
∂
−=
∂
∂ γ
 
 
Since the stationary solution of this equation must be the Maxwell-
Boltzmann distribution )2/exp()( 2 TkmvvP b−∝ , comparing it with the 
analytical solution, we get mTkb b /2
2 γ= [32]. Since this relates a quantity, 
b, characterizing the fluctuations and quantity, γ, characterizing the 
dissipation, it is called a fluctuation-dissipation relation.  
 
2.4.1 Langevin dynamics 
 
Equation 2-2 forms the basis for Langevin dynamics. Langevin dynamics 
is an approximate method that allows us to eliminate unimportant degrees of 
freedom that are substituted by the medium effects (friction) and stochastic 
forces (random forces). Langevin equation for the ith particle, in the presence 
of an external force Fi (t) can be written as: 
 
( ) ( ) ( )tRtγvmtF
dt
(t)rd
m iiii2
i
2
i +−=  
 
 where mi is the mass, γ is the damping constant or collision frequncy, 
Ri(t) is the random force, which oscillate around zero: 
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( ) 0tRi =  
 
 The effects of random forces and frictional dispersion maintain the 
thermal balance, allowing the energy of the system to oscillate without 
varying excessively. 
 
The covariance of the diagonal matrix R of the random forces Ri is 
dependent on γ: 
 
( )'BT ttTMδ2γγ)R(t)R(t' −=  
 
 where kB is the Boltzmann constant, T is temperature in Kelvin, δ(t-t') 
is Dirac delta function, and M is the diagonal matrix of dimension 3N of the 
masses mi (each repeated three times). So, the damping constant γ controls 
not only the magnitude of the friction coefficients βi=mi γ, but also the 
variance of the random forces. For large values of γ, the kinetic energy is 
quickly damped by the collisions of the solvent and the system follows 
diffusive Brownian dynamics.  
 
2.5 Common Force Fields in lipids simulations 
  
The interaction potential can be computed by several approaches of 
different complexity also including high-level ab-initio methods. However, 
for large systems, such as a lipid bilayer, the interaction between particles 
(i.e. atoms or group of atoms) is described by the molecular mechanics 
approximation, where the possibility of covalent bond formation and 
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breaking is excluded. In the molecular mechanics “ball and spring” 
approximation, atoms are considered as spheres linked together by springs. 
The force acting on every particle, and so the trajectory, is calculated from a 
potential energy function expressed a set of parameters. These parameters 
define the so-called force field, and are derived from different sources, such 
as spectroscopy or quantum mechanical calculations. The potential energy 
function comprises bonded (stretching, bending and dihedral torsions) and 
pair wise non-bonded interactions (e.g. van der Waals interactions and 
electrostatic interaction between charged atoms) [33]. 
 
Force fields can be classified as atomistic (all atoms, united atoms) or 
coarse grained, where groups of atoms are grouped into pseudo-particles. In 
the simulation of lipid bilayers, both approaches have been used. In 
particular, as an all atoms force field, the most widely used is CHARMM 
[34], and as a united atoms force field, GROMOS [35][36].  
 
In CHARMM force field, all atoms are described explicitly. CHARMM 
parameters for lipids, optimized on the condensed phase properties of alkanes 
[37], were introduced in CHARMM22 [38], and are periodically updated 
[39]. 
 
GROMOS employs a united atoms approach, and is optimized on the 
properties of pentadecane [79]. It represents each of non-polar CH, CH2 and 
CH3 as a single particle, i.e. it represents aliphatic hydrogens implicitly. Two 
main versions of GROMOS exist, the so called original GROMOS, and the 
most widely used Berger modification [40], which employs the Ryckaert-
Bellemans potential for the description of torsions of the hydrocarbon chains.  
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When a much larger time scale than possible with atomistic simulations 
is required, a simplified coarse-grained (CG) model can be used. CG models 
surfaced in the 1990s, through the work of Smit and coworkers [41], allowing 
a speed-up of 3–4 orders of magnitude compared to atomistic simulations 
[42].  A typical application of coarse-graining is in the study of the self-
assembly of lipids [43]. In CG models, groups of atoms are represented by a 
single bead. This allows a drastic reduction of the degrees of freedom in the 
simulation. The set of data against which CG force fields are optimized can 
be experimental, as in the case of the Martini force field, developed by 
Marrink and co-workers for the coarse grained simulations of lipid bilayers 
[44], or atomistic simulation data [45]. The use of the Martini model allows 
MD simulations of several microseconds, opening the door to the study of 
long time scale events such as gel phase formation [46] and hexagonal phase 
formation [41] in lipid bilayers. 
 
When force fields are extended to lipids, the main focus in 
parameterization is the reproduction of experimentally accessible properties 
like electron density profile, area per lipid, order parameters, and membrane 
thickness. This can be often achieved, but there are exceptions. As an 
example, MD simulations of the spontaneous insertion of aliphatic alcohols 
into phosphatidylcholine bilayers with the Berger force field for the lipids 
(and the GROMOS force field for the alcohols) brought partition coefficients 
for the long-chain alcohols in good agreement with experimental data, but an 
overestimated partition coefficient for ethanol [79]. Similar results were 
obtained with CHARMM27 [47]. 
 
A thorough evaluation of different force fields for lipid bilayers 
simulations can be found in [79][48][49]. Several reviews and discussions 
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have dealt with coarse grained models of bilayers [50][42]. A review of 
coarse-grain modeling of lipid bilayers appeared in [51]. 
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3 Molecular Dynamics as a tool for theoretical 
skin permeability studies. An overview. 
 
In this chapter, we review the evolution of Molecular Dynamics 
simulations of the Stratum Corneum, addressing both structural and 
permeability studies. Both fields have evolved from simulations studies on 
generic lipid and phospholipid bilayers [7][48]. So this will be our starting 
point. 
  
Kox and coworkers pioneered the field of structural studies, using MD 
simulations to study the first realistic monolayer of amphipathic molecules 
with atomistic resolution: the system consisted of 90 molecules composed of 
7 repeating CH2 units, with the first unit (the "head group") constrained in a 
plane to simulate the interaction between polar head groups [52]. Two years 
later, van den Ploeg and coworkers studied a bilayer of 2 × 16 decanoate 
molecules, applying periodic boundary conditions in two dimensions [53]. In 
the late 1980s, the work of Egberts and Berendsen on a system of sodium 
decanoate/decanol/water [54] led the way to the study of lipid mixtures. From 
that point on, the number of MD studies on bilayers began to grow 
exponentially.  
 
 The state of the art in bilayers simulations up to 1997, from the 
pioneering studies on dipalmitoylphosphatidylcholine (DPPC) and 
dimyristoylphosphatidylcholine (DMPC) in the liquid crystalline state to the 
studies on phospholipid bilayers which express a gel phase under 60°C 
(characteristic of the SC) is described in an extensive review by Tieleman, 
 36 
Marrink and Berendsen [55]. More recent studies on phospholipid bilayers 
are covered in later reviews [50][42][48][49].  
 
3.1 Structural studies on the stratum corneum lipid 
matrix  
 
Compared to the number of MD simulations performed on phospholipid 
bilayers, there are few simulation studies on ceramide bilayers. This may be 
in part due to the fact that neither CHARMM nor GROMOS are optimized 
specifically for ceramides [56].  
  
The first molecular dynamics simulation intended to mimic stratum 
corneum lipids was performed by Höltje and co-workers [57], to explore the 
effects of cholesterol. The results yielded by two systems, a FFA bilayer 
(stearic acid/palmitic acid) and a FFA/CHOL mixture at a 1:1 molar ratio are 
compared. The pure FFA bilayer is constituted by highly ordered lipid chains 
tilted relative to the bilayer normal, yielding a gel phase at 303 K. The 
presence of cholesterol increases the available free volume by decreasing the 
conformational order of the hydrocarbon chains. This effect is also confirmed 
for ternary mixtures of CER:CHOL:FFA [28]. The GROMOS87 force field is 
used for lipids, with Ryckaert-Bellemans potentials for the CH2 and CH3 
groups, and the SPC model [58] for water.  
  
The use of simplified models, possibly coupled with Coarse-Grained 
force fields, has been used to simulate phenomena requiring longer time 
scales to be observed, such as the self-assembly of a lipid bilayer [43].  
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Structural MD studies of realistic ceramide bilayers have begun to 
appear in the last ten years, and most are reviewed in [33]. It is important 
however to highlight that these include the first MD study of a ceramide 
bilayer by Pandit and Scott [59], the first study of a bilayer of asymmetric 
ceramides by Notman and co-workers [60] and the first systematic MD study 
on bilayers composed of ceramides, FFA and cholesterol at different molar 
ratios [7] by Das, Noro and Olmsted, along with other studies on mixtures by 
the same group [61][62]. Other works of note are a study on the effect of 
ceramide fatty acid chain length on the structure of bilayers [63], and a study 
on the structure and phase behavior of  CER NS and CER NP bilayers [56]; a 
study on stacked bilayers of synthetic CER EOS (methyl-branched), CER 
AP, C22:0 FFA and CHOL in a 23:10:33:33 molar ratio in water [64]; a 
study on a mixture of CER NS (24:0), lignoceric acid and CHOL in 1:1:1 
molar ratio, undergoing the addition of small quantities of oleic acid [65]. 
 
Besides the few structural simulation studies on the stratum corneum 
lipid matrix, a number of papers on MD simulations of ceramide molecules in 
different contexts [66][67] as well as simulations of sphingomyelin bilayers 
[68] have been published in recent years, but are outside the scope of this 
thesis.  
 
3.1.1 Permeation simulation studies on the stratum 
corneum  
  
The first thorough application of the inhomogeneous solubility-diffusion 
theory to solute permeation of the stratum corneum has been carried out by 
Das and colleagues [Errore. Il segnalibro non è definito.], although free 
energy calculations in ceramide bilayers had been performed before by 
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Notman and colleagues [69] relative to the study of the permeability 
enhancing mechanism of DMSO.  
 
In the work by Das and colleagues, Molecular Dynamics and the 
inhomogeneous solubility-diffusion theory are applied to water permeation. 
The water molecule is constrained at a fixed distance (z) from the bilayer 
mid-plane. The simulations are performed in the extended ensemble at 
constant temperature (350K) and constant pressure with the GROMACS MD 
package [70][71]. As  force field, a modified version of united atom OPLS 
[72] is used for the lipids and SPC [58] for water. The bilayer consists of 128 
Ceramide molecules and 5250 water molecules. Data from different 
simulations are used to calculate ∆G(z), and the diffusion coefficient in the xy 
plane and in the direction of the bilayer normal (D┴(z) and D║(z), 
respectively). Then permeability is calculated from ∆G(z) and D║(z) as 
outlined above. The simulations are then repeated with bilayers consisting of 
ternary mixtures of Ceramide:Cholesterol:Free Fatty Acid in different 
proportions at 300K and 350K. It is found that D┴(z) falls by a factor of 1000 
in the ordered tail region (while D║(z) falls by a factor of 10). This suggests 
that the ordered hydrocarbon tails define "channels" perpendicular to the 
bilayer surface. Moreover, there is a larger local density at the mid plane, 
where the interdigitation of the asymmetrical tails occurs, compared with a 
DPPC bilayer, where the diffusivity at the mid plane is the same as in bulk 
water. The permeability calculated for the 2:2:1 CER:CHOL:FFA bilayer at 
300K is about 30 times lower than the experimental value. Moreover, the 
calculation of the diffusion path according to Fick's diffusion model, from the 
calculated D║(z) and lag-time, yield an apparent path length that is 250 times 
larger than the bilayer thickness [28]. 
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4 Computational details. 
 
In this chapter the details about the purely computation aspects of the 
work are given.  From the structure of the lipid matrix model and its set-up, 
and the set-up of the 80 permeants, to the protocol followed during the 
Steered Molecular Dynamics production runs, and the choice of simulation 
parameters, the force field used, and the software packages employed for all 
those tasks. 
 
4.1 Set-up of the lipid matrix model  
 
An ideal SC lipid matrix model has been generated according to the 
model proposed by Iwai et al. [3]. It is composed by a heterogeneous mixture 
of long-chain ceramides (CERs), free fatty acids (FFAs), and cholesterol 
(CHOL) in a 1:1:1 molar ratio [6], which proved to be the most stable upon 
equilibration. Starting with a basic unit composed of one molecule each of 
CER 2 in extended conformation (Figure 4-1a), 24:0 FFA (Figure 4-1b) and 
CHOL (Figure 4-1c), a minimization by NAMD 2 and subsequent 
optimization by MOPAC 2012 [73] are performed followed by a 1 ns 
molecular dynamics at 300 K. 4 basic units (4 CER 2, 4 FFA, 4 CHOL) are 
assembled to form a monolayer unit. In each monolayer unit, one CER 2 was 
replaced by one CER 1 (thus giving a 25% of CER 1 in the ceramide 
component of the membrane), and the system undergoes a 1 ns MD 
simulation after that an energy minimization was performed. From this 
monolayer unit, membrane models of increasing sizes is built, up to a bilayer 
consisting of 868 lipid molecules (Figure 4-2). At this point, water molecules 
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are added to the model to account for solvation effects in the donor and 
acceptor phases, and a 10 ns MD simulation is performed (Figure 4-22) to 
allow to equilibrate the bilayer as confirmed by the corresponding MSD 
profile (Figure 4-3). 
 
 
 
Figura 4-1. a) Ceramide 2 (NS) in extended conformation. b) 24:0 FFA (lignoceric acid).  
c) Cholesterol. 
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Figure 4-2. The final 868 molecules bilayer before (a) and after (b) a 10 ns equilibration 
molecular dynamics in presence of explicit solvent (water). Apolar hydrogen have been 
removed from picture. Images obtained with VEGA ZZ [78]. 
 
 
Figure 4-3. Change in Root mean square deviation (RMSD) during the 10ns equilibration 
MD simulation. 
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4.2 Set-up of the permeants  
  
The below described SMD simulations were performed on the reduced 
of 80 permeants set as defined in Appendix A. This allowed us to avoid data 
in Flynn's set that do not meet the Fully validated set validation criteria 
(Appendix A), still being able to compare our results with existing models. In 
detail, the 80 molecules were simulated in their neutral form since it is 
involved in permeation processes. The conformational profile was explored 
by a quenched Monte Carlo procedure which produced 1000 conformers by 
randomly rotating the flexible torsions. For each considered permeant, the so 
obtained lowest energy conformer was further optimized by PM7 semi-
empirical calculations (also to derive more precise atomic charges) and 
underwent SMD simulation.     
 
4.3  Steered MD (SMD) simulations  
 
As a preamble it should be emphasized that the limited time period under 
investigation does not allow the spontaneous transport of molecules across 
the membrane to be simulated. Instead, steered molecular dynamics (SMD) 
simulations are used (paragraph 5.2), where solute molecules are dragged 
from water into and through the bilayer at a constant velocity in the direction 
perpendicular to the bilayer surface. SMD runs were performed on the 80 
permeants with the following characteristics: (a) periodic boundary 
conditions (108 Å x 108 Å x 162 Å) were applied to stabilize the simulation 
space; (b) Newton's equation was integrated using the r-RESPA method 
(every 4 fs for long-range electrostatic forces, 2 fs for short-range non bonded 
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forces, and 1 fs for bonded forces); (c) the long-range electrostatic potential 
was computed by the Particle Mesh Ewald summation method (108 × 108 × 
160 grid points) (d) the temperature was maintained at 300 ± 10 K by 
Langevin’s algorithm; (e) Lennard-Jones (L-J) interactions were calculated 
with a cut-off of 10 Å and the pair list was updated every 20 iterations; (e) a 
frame was memorized every 10 ps, thus generating 1000 frames; and (f) no 
constraints were imposed to the systems. The simulations were carried out in 
two phases: an initial period of heating from 0 K to 300 K over 300000 
iterations (300 ps, i.e. 1 K/ps) and the monitored phase of 2.5 ns. During this 
time, the solute molecule was forced to cover a distance of 50 Å at a speed of 
0.02 Å/ps by applying a harmonic constraint force equal to 5 Kcal/mol/Å2.  
 
Though the trajectory imposed on the solute in the SMD simulation 
doesn't necessarily follow the same tortuous path as in the physical system 
[9], the solute experiences all the microenvironments that can be encountered 
in a real permeation process. In detail, the trajectory imposed on the solute in 
the SMD simulation doesn't follow the route through the least dense region. 
Instead, the solute is made to follow the transversal route through the polar 
headgroups. This allows for an investigation of the behaviour of the 
permeants along the whole double layer, through all the possible 
microenviroments, without prejudice about which one is the path of least 
resistance, thus exploring the entire conformational and physicochemical 
property space [74] as the molecule moves through the bilayer. 
 
As physicochemical properties, polar surface area (PSA), surface, and 
lipophilicity (Virtual logP) [75] are considered, averaged in the different 
zones of the bilayer. The automatic linear regression script in VEGA ZZ is 
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used to find a correlation between the physicochemical properties and the 
permeation coefficient for the set of solutes. Other descriptors that can be 
derived directly from the SMD simulations, such as the force acting on the 
solute molecule, have proved of little value. Improvements for the estimation 
of the molecule behaviour, such as Free Energy calculations [26] couldn't be 
applied so far. As a matter of fact, a Free Energy calculation from a SMD 
using Jarzynski equality [76] would require multiple trajectories for every 
solute, and that is unfeasible for a screening of 80 molecules. 
 
4.4 Simulation parameters 
 
Molecular dynamics simulations are performed using NAMD 2 [77] and 
VEGA ZZ [78] software packages, on consumer grade desktop computers. 
The force fields used are CHARMM 36 [39] for the lipids, and the SPC 
potential [58] for water. In CHARMM force field, all atoms are described 
explicitly. CHARMM parameters for lipids, optimized on the condensed 
phase properties of alkanes [79], were introduced in CHARMM22 [80], and 
are periodically updated [Errore. Il segnalibro non è definito.]. 
 
All lipid molecules were in non-ionized form, as well as all solute 
molecules. A correction has been applied to the experimental Kp of 
molecules that are partially ionized at experimental conditions, based on the 
estimate of the non-ionized fraction [81]. 
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5 Theoretical background 
  
In this chapter, the theoretical background to our work is presented in 
detail. First, an account of the inhomogeneous solubility-diffusion model, 
developed by Marrink and Berendsen for studying membrane permeation is 
given. Then an explanation is given of the molecular properties and quantities 
used in Chapter 6. 
 
The inhomogeneous solubility-diffusion model represents an important 
approach to the problem, but it is based either on equilibrium MD simulations 
or on multiple non equilibrium MD simulations. Neither of these two cases 
applies to our work, since it was our goal to explore the different regions of 
the lipid matrix and to screen a large number of permeants. Either of this two 
goals requires multiple simulations: multiple equilibrium simulations in 
different regions or multiple SMD (non-equilibrium) simulations needed for 
calculating Free Energy differences from Jarzinsky equality (Paragraph 
5.2.1). 
 
An alternative method, which was explored in our work, was to use 
SMD simulations to explore the conformational space and property space of 
the permeants [82]. SMD simulations lead to the exploration of a reduced 
space, with respect to a conformational search, since MD takes naturally into 
account the environment. So only the conformational and property subspaces 
explored by the molecules in the lipid matrix are considered. 
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5.1 Molecular Dynamics simulations of solute 
permeation: the inhomogeneous solubility-
diffusion model 
  
The use of MD simulations to study solute diffusion through lipid bilayer 
membranes was developed in the 1990s for phospholipid bilayers, starting 
with early studies on passive diffusion [23][24][25] to systematic studies of 
permeation by Marrink and Berendsen, which took into account diffusion and 
solubility of penetrants into the membrane [26][27], and the statistical 
mechanics studies of MD trajectories by Xiang [83]. A thorough review of 
the first works on solute permeation of biomembranes can be found in [55]. 
More recent works has been reviewed in [84] and [14]. 
 
The inhomogeneous solubility-diffusion model, developed by Marrink 
and Berendsen, accounts for the non-homogeneity of biomembranes. Though 
the model is rigorously derived in [26], a simplified derivation is proposed 
here, with the same a priori assumptions, to highlight its physical meaning 
and applicability. If the membrane is homogeneous, the total resistance R (for 
our purpose, defined as the inverse of the permeability coefficient Kp) 
opposed by the bilayer to solute permeation is (Equation 1): 
 
KD
h
K
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In a non-homogeneous membrane, as K, D, and therefore R are a 
function of depth z, the total resistance R can be expressed as the sum of the 
infinitesimal resistances dR : 
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over the bilayer thickness h, yielding [84][33]: 
 
∫=
h
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  Equation 5-1 
 
where K(z) is the partition coefficient from water into the membrane at 
depth z, D(z) is the diffusion coefficient at depth z. 
  
The integral in Equation 5-1 assumes that the permeant moves, 
predominantly, along the direction of the bilayer normal, z, thus going 
through all the barriers of resistance dR 'in series'. It is rigorously valid for 
plasma membranes, where a solute undergoing passive permeation has to 
reach the inside of the cell from the outside. On the other hand, the different 
topology of the SC allows the permeant to follow a tortuous path [15][28], 
which will be a combination of motion along the bilayer normal and 
perpendicular to it. One of the models proposed for lipids arrangement 
assumes that trans-bilayer steps are not required during the permeation 
process, and a continuous path without interruptions along the whole SC 
depth is allowed [15]. In this case, the permeant could avoid the zones of 
higher resistance along the bilayer normal, which will thus make a negligible 
contribution to the integral in Equation 5-1. As a consequence, the total 
resistance R will be lower, and the permeation coefficient will be higher than 
calculated through Equation 5-1, as observed by Das and colleagues for a 
water molecule [28]. 
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In general, the calculation of the total resistance R in the case of the SC 
will require a generalization of Equation 5-1, accounting for the importance 
of lateral diffusion [9], and for the effective path followed by the solute. An 
expression for R, for example, could take the form of a line integral over the 
solute's effective path L' in the SC lipid matrix: 
 
∫=
'
)()(L LKLD
dLR    Equation 5-2 
 
where D(L) and K(L) are the path-dependent partition and diffusion 
coefficients at point L along the solute's path, respectively. Note that the 
relevant quantities in Equation 5-2, D(L) in particular, lacks a clear definition 
in this formulation. Further refinements of the equation, though, are outside 
the scope of this work. A review of relevant papers about the effects of SC 
topology on effective path length calculation is contained in [15]. 
 
5.1.1 Estimation of diffusion and partition coefficients with 
Molecular Dynamics 
 
Molecular Dynamics performed on bilayers naturally accounts for the 
anisotropic and non-homogeneous structure of biomembranes, where the 
partition coefficient K(z) and the diffusion coefficient D(z) are a function of 
depth z inside the bilayer. The diffusion coefficient will have different values 
in the direction or parallel (z) or perpendicular (xy) to the bilayer normal. 
 
The local diffusion coefficient D(z) can be calculated in different ways 
from Molecular Dynamics trajectories, the simplest method being from the 
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mean square displacement (MSD). For diffusion in the z direction (but the 
reasoning can be extended to calculation in the xy plane) [86]:  
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 Equation 5-3 
 
where the average  is, theoretically, over different system replicas, 
but it is replaced, for our purposes, with the time average, a procedure that 
would be rigorous only if the ergodic hypothesis could be verified (which is 
seldom the case).  The limit of this approach is that, as the solute diffuse it 
goes through regions with different diffusion coefficient, so that Equation 5-3 
is applicable only to short time diffusion periods [86]. 
 
In this work, both Dz and Dxy were calculated from the MSD (in the z 
direction and in the xy plane, respectively) obtained from the simulations, 
using the algorithm proposed by Cameron Abrams [85]. 
 
A more general approach relates D(z) to the force fluctuations. In the 
case of a solute constrained at depth z by a force ),( tzF , the diffusion 
coefficient can then be expressed in terms of the time integration of the 
autocorrelation function of the random forces ),( tzF∆  [86]: 
 
∫
∞
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where the random forces ),( tzF∆  are calculated as the deviation of the 
instantaneous force ),( tzF  acting on the constrained molecules from the 
average force ),( tzF :  
 
),(),(),( tzFtzFtzF −=∆ . 
  
The partition coefficient K(z) can be calculated from the free energies of 
solute partitioning from water to depth z of the bilayer [14]:  
 
( )RTzGzK )(exp)( ∆−=  
where 
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where 
t
zF )'(  is the constraint force at position z' averaged both over 
time and over different system replicas, and so a large number of different 
simulations are required for free energy calculations. 
 
Once the partition and diffusion coefficients are estimated using the 
above methods, the permeability coefficient Kp can be calculated from 
Equation 2 [83][84][86]. The model, initially applied to the study of 
membrane permeation by water [26], was later applied by the same Authors 
to ammonia, and oxygen molecules [27][87]. It has become widely used as a 
model for biomembrane permeation studies, as in the case of small molecules 
[88], β-blocker drugs [89] and valproic acid [90]. 
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5.2 Force, Work and Free Energy differences 
 
In a constant velocity Steered Molecular Dynamics simulation, the center 
of mass of the tagged atoms (in our case the center of mass of the permeant) 
is harmonically constrained (with force constant k) to move at constant 
velocity v in the direction nr . The situation is equivalent to having a "dummy 
carrier" moving at velocity v in the direction nr , bound to the center of mass 
of the tagged atom with a spring of force constant k. So the potential applied 
to the moving atoms is: 
 
[ ]221 ))0()((21),...,,( nRtRvtktrrU
rrrrr
⋅−−=  
 
where )(tRr  is the position of the center of mass at time t, and )0(Rr is the 
position of the center of mass (at the start of the simulation) as defined by the 
input PDB file. The force applied to the center of mass of the tagged atoms is 
then: 
 
UF ∇−=
rr
 
 
and it is calculated through Hooke's law, from the force constant k and 
the elongation of the spring: nRtRvt r
rr
⋅−− ))0()(( . 
 
In the course of our simulations, value of the force was stored every 3 ps, 
for a total of 833 force values during a 2.5 ns simulation. The work 
performed by this force could be calculated as well. Unfortunately, the 
system not being in equilibrium, the calculated work has little significance, 
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since it cannot be related to Free Energy changes. The calculation of Free 
Energy requires performing multiple (usually 10) simulations for each system 
and the applying Jarzinsky equality. Since our work consisted in the 
screening of more than 90 molecules (initially) the use of multiple 
simulations was unfeasible. 
 
Force values though can bring qualitative insight on the behavior of the 
permeant in the different molecular environments. A typical progress of 
Force vs Position is shown in Figure 5-1. 
 
 
 
Figure 5-1. Force vs Position for Sucrose (blue) and Estradiol (magenta). 
 
 
In Figure 5-1, it is clear that the hydrophilic molecule encounters more 
resistance in the ceramide phases (more exactly ceramide + cholesterol and 
ceramide + free fatty acids phases), while the hydrophobic molecule 
encounters a resistance peak in the polar heads region. Since the path 
imposed on the permeant during the in silico simulation, though, is not 
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necessarily the path followed by the molecule in vitro, these "obvious" 
energy barriers are not real, and could not be correlated to permeability 
coefficients. 
 
5.2.1 Free energy calculations from multiple trajectories 
  
For three molecules, namely pentanoic acid, progesterone and styrene, 
multiple trajectories were obtained. The goal was to study the effect of a 
(admittedly large) perturbation in initial conditions. The perturbation only 
affected the initial x-y position of the permeant's center of mass (COM). In 
the Trajectory 1 the permeant's COM is placed at x = 0, y = 0 at the 
beginning of the simulation. Trajectory 2 replicates the same initial position 
as Trajectory 1. In the other trajectories, it is displaced by 1 Å at a time along 
x and along y. The starting points for trajectories 2 to 5 are so (in Å): 
 
• trajectory 3: x = 0, y = 1  
• trajectory 4: x = 1, y = 0 
• trajectory 5: x = 1, y = 1 
 
Even though the perturbation seems large, it should be noted that the 
permeants undergoes an erratic movement in water at the beginning of the 
simulation, for 10-15 Å. So the point of insertion into the SC is quite 
unpredictable. This is particularly true for small molecules, whose low linear 
moment makes the movement in water highly erratic. Though the trajectory 
starting at (0, 0) is taken as a reference, it has no special meaning, as it can 
lead to unusable pathways at the edges of the simulation box, as in the case of 
4-bromophenol (Figure 5-2), for which the trajectory starting (0, 0) clearly 
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ends in a region outside the model membrane (which goes approximately 
from -34 Å to +32 Å in the x direction, and from -35 Å to +35 Å in the y 
direction). 
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Figure 5-2. x (Å) vs. y (Å) plot for the trajectory starting at (0,0) for 4-nitrophenol. 
 
In Figures 5-3, 5-4, 5-5, the x-y plots of the trajectories for pentanoic 
acid, progesterone and styrene, respectively are depicted. In the case of 
progesterone and styrene, trajectories 3 and 5 (yellow and purple lines) are 
clearly outside the model membrane, and have to be omitted from further 
analysis. 
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The availability of multiple trajectories, allows us to use Jarzinsky 
equality for the calculation of Free Energy differences (in our case Helmholtz 
Free Energy), from the work done by the SMD force in the different 
simulations. Jarzinsky equality states that: 
 
kTWkTF ee // −∆− =
 
 
where ∆F is the Free Energy difference associated with the trajectory, W 
is the work done by the SMD force for the same process, k is Boltzmann's 
constant, T the absolute temperature. The average is taken over an ensemble, 
in our case over the different trajectories. 
  
In Figures 5-6, 5-7 and 5-8, the work W is depicted for the different 
trajectories for the 3 molecules under study, as well as the Free Energy 
difference ∆F. From the plots, it is clear that in most cases the work 
calculated from SMD simulations is higher than the Free Energy difference, 
confirming that the simulations are away from equilibrium. Work calculated 
in our simulations cannot be used as such to estimate Free Energy. 
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Figure 5-3. x (Å) vs. y (Å) plot for the 5 trajectories for pentanoic acid. 
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Figure 5-4. x (Å) vs. y (Å) plot for the 5 trajectories for progesterone. 
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Figure 5-5. x (Å) vs. y (Å) plot for the 5 trajectories for styrene. 
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Figure 5-6. Work and Free Energy difference plot for pentanoic acid. 
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Figure 5-7. Work and Free Energy difference plot for progesterone. 
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Figure 5-8. Work and Free Energy difference plot for styrene. 
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5.3 Molecular Dynamics simulations of solute 
permeation: exploration of conformational and 
property space 
 
The concept of a property space, as the space of conformer-dependent 
properties experienced by a molecule when exploring its conformational 
space, was introduced by Bernard Testa and colleagues in [91], and later 
applied to the exploration of lipophilicity space in [82]. Fundamental in the 
development of the concept of property space were the assumptions that for a 
conformation-dependent physicochemical property: 
 
1. a flexible molecule will assume different values dependent on the 
conformation; 
2. the average value of a property, particularly a weighted average (and 
also its range), is more indicative than any conformer-specific value. 
 
MD simulations represent a viable technique for the exploration of the 
conformational space of a molecule in a specific, and explicitly described, 
environment. In our particular case, and SMD simulation spanning the length 
of a SC monolayer, allowed the exploration of the conformational spaces of 
the 80 permeants in the reduced set (Appendix A). If conformation-dependent 
physicochemical properties are calculated at regular intervals, this results in a 
concurrent exploration of property space in the same environment. 
 
 Different molecular properties can be calculated during a SMD 
simulation. The "static" properties are calculated for example on optimized 
geometries in vacuum with ab-initio or semi-empirical quantum mechanics 
calculations. Molecular Dynamics allows for the determination of 
 60 
"dynamical" properties, i.e. the relevant properties are calculated for the set 
of molecular geometries encountered in the actual molecular environment. 
 
5.3.1 Physicochemical properties 
 
The physicochemical properties considered were conformation-
dependent properties, in particular virtual log P (calculated by a MLP 
approach) [75], polar superficial area (PSA), lipole, surface (calculated with a 
probe of diameter 1.40 Å), ovality and frontal area. Even properties which 
have little dependence on conformation, like molecular volume (MV) or no 
dependence, like molecular weight (MW) were considered. As the partition 
coefficient of a molecule plays a key role among physicochemical properties, 
a detailed account is given on the method used to estimate its value. 
 
5.3.2 MLP and virtual log P 
 
"The MLP defines the influence of all lipophilic fragmental contributions 
of a molecule on its environment. The MLP value at a point in space is 
generated as the result of the intermolecular interactions between all 
fragments in the molecule and the solvent system, at that given point" [75]. 
 
In practice, MLP in a given point in space k is expressed (and calculated) 
as the product of the lipophilic constant of a fragment i and a distance 
function fct(dik), where dik is the distance between fragment i and point space 
k, integrated over all the fragments in the molecule: 
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where N is the total number of fragments in the molecule. In particular, 
the MLP used is based on the atomic lipophilic system of Broto and Moreau 
and on an exponentially decaying distance function: 
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To obtain a quantity that can be correlated with experimental log P, the 
MLPk values so obtained are integrated, either by summation over all MLP 
values on the surface (∑MLP ) or by summation of the positive MLP values 
( +∑MLP , representing the "lipophilic" part of the molecule) and the 
negative MLP values ( −∑MLP , representing the "hydrophilic" part of the 
molecule ) separately. These three parameters,  ∑MLP , 
+
∑MLP  and 
−
∑MLP  are dependent on the tridimensional structure of the molecules, and 
the log P generated by the MLP through linear correlation with experimental 
log P values, called the "virtual log P" is dependent on molecular 
conformation [75]. 
 
5.3.3 Frontal area 
 
One the quantities that showed some correlation to the permeation 
coefficient, was the Frontal area, i.e. the projection of the molecule in the xy 
plane, calculated as Volume/z-dimension. A frontal area so calculated gives a 
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good approximation in the case of cylindrically molecule, but it gives an 
underestimated measure in the case of a spherically shaped molecule. In the 
latter case, the z-dimension is the sphere diameter, so: 
 
23 πR
3
22RπR
3
4(sphere)areafrontalEstimated ==
 
 
which is 2/3 of the true frontal area. A better estimation of the frontal 
area is obtained by multiplying the value of Volume/z-dimension by the 
quantity 3/(2*ovality), which has value 3/2 for a sphere and approximately 1 
for a cylinder. 
 
5.3.4 Scoring functions 
  
A different approach consisted in the evaluation of the SC-permeant 
interaction energy through a scoring function. Five different scoring 
functions  were tested,  of which four are variations of the MLP Interaction 
Score [92]: MLPInS, MLPInS2, MLPInS3, MLPInSF and CHARMM.  
 
"The MLP Interaction Score (MLPInS) is computed using the atomic 
fragmental system proposed by Broto and Moreau and a distance function 
that defines how the score decrease with increasing distance between 
interacting atoms.  The equation to compute the interaction score is: 
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where fa and fb are the lipophilicity increments for a pair of atoms and 
rab is the distance between them. The first sum is over all the ligand’s atoms, 
the second sum is over all receptor’s atoms.  
 
The basic assumption in the calculation of the MLPInS, which encodes 
the contributions of the various intermolecular forces measured 
experimentally in partition coefficients, is that the score is favourable (i.e. 
negative) when both increments have the same sign (as denoted by the 
negative sign in the equation), or unfavourable (repulsive forces) when the 
score has a positive sign. When the atomic parameters are both positive, 
MLPInS encodes hydrophobic interactions and dispersion forces, the 
importance of which is well recognized in docking simulations, and it 
accounts for polar interactions, in particular H-bonds and electrostatic forces 
when the atom parameters are both negative" [92]. 
 
The tested MLP Interaction Scoring functions differ in the calculation of 
hydrophobic interaction: 
 
• in MLPInS, hydrophobic interaction is calculated as product of the 
Broto's and Moreau's atomic constants divided by the distance 
between the interacting atom pair; 
• in MLPInS2, as above, but the distance between interacting atom pairs 
is considered as a square value; 
• MLPInS3, as above, but the distance between interacting atom pairs is 
considered as a cube value; 
• MLPInSF, as above, but the distance is evaluated by Fermi's equation. 
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In the CHARMM scoring function, Van der Waals interactions are 
estimated by CHARMM 22 force field. 
 
5.4 On the confidence interval of the correlation 
coefficient r 
 
Given the uncertainty in the experimental data contained in Flynn's data 
set and even in the Fully validated data set (Paragraph 5.4.1), it is important 
to estimate a confidence interval for r or r2 and to know if there is a 
theoretical maximum correlation coefficient for a set of data with given 
uncertainties. 
 
In determining the confidence interval of r, where r is seen as an 
estimate of a true value ρ, a first analytical method applied the approach 
devised by R.A. Fisher [93], using the Fisher r → Z transform [94][95], 
which is defined as: 
 
r)]ln(1r)[ln(1
2
1Z −−+=      Equation 5-4 
 
The transformed variable Z has a different behaviour than r. It tends to a 
normal distribution as the number of data (n) becomes larger, and its variance 
sZ
2
 is independent on the value of r: 
 
3
12
−
=
n
sZ     Equation 5-5 
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To get a confidence interval for r, the value of r is transformed into Z, a 
confidence interval is calculated for Z and it is transformed in the confidence 
interval of r, using the reverse transform: 
 
1
1
2
2
+
−
= Z
Z
e
e
r   Equation 5-6 
 
Results obtained through Fisher r → Z transform are independent of the 
uncertainty of experimental data and require the r value is known a priori. 
Even though the r2 mean of a correlative analysis based on a dataset 
characterized by a known standard deviation of the errors, ε, is roughly equal 
to 1 - ε, a numerical simulation was performed to better investigate the 
correlation between the confidence interval of r and the uncertainty of 
experimental data. As described below, such a simulation involved the 
introduction of increasing random errors into the experimental pKp data to 
analyse their influence on the correlation coefficient. Moreover, by repeating 
many times the numerical simulation, it is possible to derive both the mean r2 
and the corresponding a confidence interval as defined by the corresponding 
minimum and maximum of r2 values. Interestingly, these numerically derived 
results will be compared to those calculated by using the Fisher transform. 
Both methods are applied to the 80 compounds in the reduced set and 
compared in Table 5-1 (r2 values are given). 
 
In the simulation, yi are the experimental pKp (= -logKp) for the 80 
compounds in the data set: 
 
yi  = -logKpi  i = 1,2 ... n 
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We suppose to have a perfect estimator φ for yi, so that given a set of 
variables {xij}, where xij represents the jth molecular property of the ith 
molecule, the equation: 
 
yi  = φ(xij)  i = 1,2 ... n, j = 1, 2 ... n    
Equation 5-7 
 
brings a correlation coefficient r = 1. 
 
For every yi, we now introduce an error, ε·ci·yi, where the ci values are 
normally distributed pseudo-random numbers with zero average and unitary 
standard deviation, and ε corresponds to the standard deviation of the errors, 
normalized by yi. Equation 5-7 becomes: 
 
yi (1 ≤ ε ci) = φ(xij)  i = 1, 2 ... n, j = 1, 2 ... n 
Equation 5-8 
 
which has a correlation coefficient r < 1. For increasing values of ε (from 
0.1 to 0.5), we repeated the simulation 99 times by applying Equation 4-6 to 
the same set {yi, xij}, each time changing the set {ci}. Since the so calculated 
correlation coefficients (rk) are not normally distributed, we apply Fisher r → 
Z transform to obtain 99 Zk values, for which the standard deviation is 
calculated: 
 
∑
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Once the confidence interval for Z, has been calculated as )SZ,SZ( zz +− , 
the reverse transform is used to get a confidence interval for r (Figure 5-9). 
Results of the simulation, performed on the 80 compounds in the reduced 
data set are listed in Table 5-1.  
 
The normally distributed pseudo-random numbers are obtained starting from 
random numbers and applying the Box-Muller transform. Given a set of pairs 
of random numbers {ui, uj} in the interval (0, 1), the set {ci, cj}, where ci, cj 
are defined by: 
 
)sin(2πi2lnuc
)cos(2πo2lnuc
jij
jii
−=
−=
 
 
The Box-Muller transform allow to obtain a set of normally distributed 
pseudo-random numbers, with zero average and unitary standard deviation.  
 
 
ε 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50 
r2 mean simulated 0.95 0.88 0.81 0.74 0.66 0.59 0.53 0.47 0.42 
r2 lower simulated 0.93 0.86 0.77 0.68 0.58 0.50 0.43 0.36 0.31 
r2 higher simulated 0.96 0.91 0.85 0.79 0.73 0.68 0.62 0.57 0.53 
r2 lower calculated 0.93 0.86 0.77 0.69 0.60 0.52 0.45 0.39 0.34 
r2 higher calculated 0.96 0.91 0.85 0.79 0.72 0.66 0.60 0.55 0.51 
 
Table 5-1. Mean and confidence interval for r2 obtained from numerical simulation 
(simulated), corresponding to different values of standard deviation of pKp (ε = Std. dev. of 
pKp / average pKp). Mean and Confidence interval for r2 (calculated) obtained from 
Equations 5 and 6 corresponding to the simulated r2 mean value 
 
 
Results in Table 5-1 show how the correlation worsens when the 
uncertainties on experimental data increase even considering an ideally 
perfect estimator of for yi. Mean r2 values decrease as an S-shaped function 
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as ε increases (Figure 5-9). As expected and to a first approximation mean r2 
mean values can be estimated as 
 
r
2
 = 1- ε 
 
which implies that even a perfect estimator for pKp cannot explain all the 
variability associated in the experimental data, given their uncertainties. 
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Figure 5-9. Mean r2 values vs. different values of standard deviation of pKp (epsilon = Std. 
dev. of pKp / average pKp). 
 
 
5.4.1 Uncertainty in experimental data and repercussions of 
the correlation coefficient 
 
To get an idea of the typical uncertainties of the pKp values in the existing 
datasets, we consider compounds for which multiple (more than 2) 
measurements are included in the FV data set (Figure 5-2), and calculate the 
standard deviation of pKp normalized by the pKp average. This term can then 
be compared to ε from Equation 5-8. As it can be seen from Table 5-2, values 
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of ε of 0.25 or greater are possible. Results from the simulation are shown in 
Table 5-3. 
 
Corticosterone (n=4)        pKp     t (∞C) 
  
Phenol (n=3)        pKp     t (∞C) 
Average 3.67 29.25   Average 2.53 28.00 
St. Dev. 0.94 6.55   St. Dev. 1.12 7.94 
St. Dev./Average 0.26 0.22   St. Dev./Average 0.44 0.28 
              
Estradiol (n=5)        pKp     t (∞C) 
  
Ethanol (n=3)        pKp     t (∞C) 
Average 2.52 31.00   Average 3.37 25.67 
St. Dev. 0.58 4.00   St. Dev. 0.24 4.04 
St. Dev./Average 0.23 0.13   St. Dev./Average 0.07 0.16 
              
Mannitol (n=4)        pKp     t (∞C) 
  
Water (n=8)        pKp     t (∞C) 
Average 4.09 31.50   Average 2.96 29.88 
St. Dev. 0.12 5.20   St. Dev. 0.20 2.10 
St. Dev./Average 0.03 0.16   St. Dev./Average 0.07 0.07 
              
Salicylic acid (n=3)        pKp     t (∞C) 
  
Octanol (n=3)        pKp     t (∞C) 
Average 1.72 34.67   Average 1.26 25.67 
St. Dev. 0.43 4.04   St. Dev. 0.04 4.04 
St. Dev./Average 0.25 0.12   St. Dev./Average 0.03 0.16 
 
Table 5-2. Average and standard deviation for pKp and temperature (t, ±C) based on data 
included in the Fully Validated data set and published in [81]. 
  
 
 ε 0.05 0.1 0.15 0.2 0.25 0.3 0.4 
r mean 0.993 0.973 0.94 0.90 0.86 0.82 0.73 
r low 0.992 0.968 0.93 0.88 0.83 0.77 0.66 
r high 0.995 0.979 0.96 0.93 0.89 0.86 0.79 
r2 mean 0.986 0.948 0.89 0.82 0.74 0.67 0.53 
r2 low 0.984 0.936 0.87 0.78 0.69 0.60 0.44 
r2 high 0.989 0.959 0.91 0.86 0.80 0.74 0.63 
 
Table 5-3. Mean and Confidence interval for r and r2 obtained through numerical simulation, 
corresponding to different values of standard deviation of pKp. ε = (Std. dev. of pKp) / 
(average pKp). 
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There is a correlation (r2 = 0,64) between the normalized standard 
deviation of pKp and the normalized standard deviation of experimental 
temperatures, suggesting that the effect of temperature should be taken into 
consideration for a better correlation of pKp to the molecular properties, 
either in the form of a correction factor or performing the MD simulations at 
the same temperature as the experiment. 
 
 
5.5 On the linear filtering of differential and exponential 
quantities. 
  
When dealing with quantities with a rich higher harmonics content, such 
as position and force data derived from Molecular Dynamics simulations, a 
certain degree of filtering seems necessary. A word of caution, though, is due 
if linear filtering is to be applied to quantities, such as position, which are
 
 
Figure 5-10. Position coordinate of the center of mass of a molecule in a SMD simulation 
(magenta) and a 37 period MA (blue). 
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later manipulated to obtain differential quantities, such as velocities (and so 
even the Mean Square Deviation, MSD, used to derive the Diffusion 
coefficient) or exponential quantities such as kinetic energy. 
 
The hypothesis when applying filters for the purpose of reducing the 
casual error in calculation/measurement, is that the error is indeed casual, 
with zero average. A typical signal from an SMD simulation, for example a 
position coordinate (but it could be a linear momentum or a force), with 37 
period Moving Average (MA) applied to it as a filter is shown in Figure 5-10. 
 
The MA is defined as: 
 
 
 
The value ix  can be thought of as a true value TRUEix ,  plus a casual error 
iε , which can be positive or negative: 
 
iTRUEi,i εxx +=  
  
Since iε , 0
1
→∑
N
iε  as ∞→N  then, if N is sufficiently large: 
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and so, from the definition of MA: 
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)MA(x)MA(ε)MA(x)MA(x TRUEi,iTRUEi,i ≈+=  
 
which allows as to take the MA of ix  as an estimate of the true value 
TRUEix , . Then, the casual error iε  can be calculated as: 
TRUEiii xx ,−=ε  
as depicted in Figure 5-11. 
 
The average error ∑
N
iN 1
1
ε clearly goes to zero as the number of 
timeframes increases (Figure 5-12). 
 
 
 
Figure 5-11. Estimation of the casual error iε  in the determination of  the position 
coordinate ix of the center of mass of a molecule in a SMD simulation. 
 
 
If we take the square of the coordinate from the SMD simulation 2ix , as 
in the case of calculating kinetic energy from the linear momentum, and the 
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square of the MA of ix  as an estimate of its true value 
2
,TRUEix , clearly the 
error [ ]22* )( iii xMAx −=ε  shown in Figure 5-13, is not casual and it does not 
have in general zero average as the number of timeframe increases (Figure 
5-14). 
 
 
Figure 5-12. Average of the casual error iε  in the determination of  the position coordinate 
ix of the center of mass of a molecule in a SMD simulation. 
 
 
Figure 5-13. Error [ ]22* )( iii xMAx −=ε  in the determination of  the square of coordinate 
ix  in a SMD simulation. 
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Indeed, as iTRUEi,i εxx += then: 
 
2
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2
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2
i εx2εxx ++=  
 
where iε  is the casual error. If we take [ ]2)( ixMA  as an estimate of 
2
,TRUEix , then: 
[ ] [ ] 2iii2i2i*i ε)MA(x2ε)MA(xxε +=−=  
 
and the average of *iε : 
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clearly does not tend to zero as N increases (Figure 5-14). 
 
 
 
Figure 5-14. Average of error [ ]22* )( iii xMAx −=ε  in the determination of  the square of 
coordinate ix  in a SMD simulation. 
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In the case of a differential quantity iii xxx −=∆ +1 , such as velocity if 
ix is a position coordinate (Figure 5-15), if we filter the original coordinates 
ix  and 1+ix  with a MA of period p, then we get: 
 
2/)1(2/)1(1 )()( −−+++ −=−=∆ pipiipipi xxxMAxMAx  
Equation 5-9 
 
So we are simply replacing a difference between adjacent x values, with a 
difference between x values at the extremes of the MA period. This only 
means a loss of information instead of filtering. Since MA is a linear operator, 
applying the MA to ix∆  instead of applying it to ix  and 1+ix  brings the same 
result. 
 
If we apply a multiple pass moving average, i.e. we apply a MA of 
period p to ix∆  as calculated in Equation 5-9, we get: 
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So we are replacing a difference between adjacent x values, with a 
difference between moving averages centered at the extremes of the first MA 
period. 
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Figure 5-15. Differential quantity iii xxx −=∆ +1  derived from coordinate ix . 
 
Other linear filters, such as Savitsky-Golay filters, bring different results, 
but there is always a loss (albeit smaller) of information around the values to 
be subtracted, and their replacement with a linear combination of neighboring 
values. A Savitzky-Golay filter has the general form: 
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where integer coefficients jc  have different values based on the width 
and polynomial degree of the filter. For example, in a quadratic filter of width 
5, the coefficients are: -3, 12, 17, 12, -3.  
 
 
Figure 5-16. Coefficients jc of a Multiple (Double) Pass Moving Average of period p 
applied to the differential quantity iii xxx −=∆ +1 . 
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In the case of the moving average, the coefficients of the linear 
combination are uniformly distributed (Figure 5-16), while in the case of 
Savitsky-Golay filters values far from the original coordinates to be 
subtracted have the lowest weight (Figure 5-17). 
 
 
Figure 5-17. Qualitative trend of the coefficients jc of a Savitzky-Golay filter applied to the 
differential quantity iii xxx −=∆ +1 . 
 
 
An advantage of Savitzky-Golay filters over MAs in the case of 
differentials though, is that the filter can be applied to the signal to calculate 
directly the 1st derivative, thus avoiding the loss of information. 
 
The loss of information could be resolved in different ways, for example 
using non-linear filters, or applying the 1st derivative Savizky-Golay filter. 
We chose the simplest method of taking the median of a value (be it position, 
or a molecular property) inside the relevant Stratum Corneum region. 
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6 Predictive analyses 
 
In this chapter, the results obtained in the search of a predictive equation 
of skin permeability to chemicals are shown. The chapter starts with the 
preliminary explorations of semi-empirical equations,  based on the Potts and 
Guy equation, without the use of Molecular Dynamics, which can be refined 
to give results at the limit of what is possible given the uncertainty in 
experimental data (Paragraph 5.4) at the risk of overfitting the available data 
(n = 80). Then, results obtained from MD simulations are given. Two 
different path have been attempted:  
 
1. the use of position and force data from SMD simulations. The use of 
force data to calculate work and then Free Energy differences had to 
be discarded, because our simulations are to far from equilibrium 
(Paragraph 5.2.1) to yield correct Free Energy values. Moreover, 
since our work consist of a screening of a large number of molecules 
performing multiple simulations (from 5 to 10 at least) proved 
unfeasible. Position data, on the other hand were used to calculate 
Diffusion Coefficients. 
2. the use of MD simulations as a mean to explore the conformational 
space and property space of the permeants, in a real-world scenario, 
i.e. on a reduced conformational and property subspaces, that the 
molecules are likely to explore during the process of Stratum 
Corneum permeation. 
 
In practice, in the best predictive equations, we mixed molecular 
properties from step 2 with diffusion coefficients from step 1. 
 80 
 
All correlations in the present chapter (except for the Potts and Guy 
equation) are performed on the reduced data set defined in Appendix A. 
 
6.1 Predictive models based on Potts & Guy equation 
  
The most cited semi-empirical model of permeability is the one by Potts 
and Guy [8], whose equation (correlated on Flynn's set of 94 permeants) is:  
 
logKp (cm/s) = – 6.3 + 0.71 log Ko/w – 0.0061 MW  r2 =0.68 
 
where Kp is the permeability coefficient expressed in cm/s, Ko/w the 
octanol/water partition coefficient, MW the molecular weight and r the square 
of the correlation coefficient calculated on Flynn's set. 
 
As pointed out in the previous chapter, a temperature correction factor 
may be added to a predictive equation, to account for the variability in 
experimental conditions both in Flynn's [10] and in the Fully Validated [81] 
sets. Introducing  the effect of temperature on reducing the activation energy 
for transport of penetrants through the SC, Vecchia and Bunge [81] proposed 
the modified equation: 
 
logKp = a + b · log Ko/w + c · MW/T  Equation 6-1 
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where T is the absolute temperature, and a, b, c the coefficient to be 
determined empirically. It is notable that Equation 6-1 has the same degrees 
of freedom as the Potts & Guy equation. Applying Equation 6-1 to the 
reduced set (since not all experimental temperatures are known for Flynn's 
set), we get the following result, not significantly better than Potts & Guy's: 
   
logKp (cm/s) = -6.22 + 0.62 log Ko/w - 1.72 MW/T   
r
2
 = 0.69, q2 = 0.66, n = 80 
 
where q2 is the square of correlation coefficient obtained with the Leave 
One Out (LOO) algorithm, and it is a measure of the predictive power of the 
equation. 
 
Surprisingly, replacing the absolute temperature T with temperature t in 
±C, r2  and q2 improve: 
 
logKp (cm/s) = -5.97 + 0.64 log Ko/w - 0.21 MW/t Equation 6-2 
 r
2
 = 0.75, q2 = 0.70, n = 80 
 
Since this result relies only on a change in unit of measure, it seems 
suspect of overfitting of data, and it should be tested on larger data sets, such 
as the full Fully Validated data set. However, since the dependence of logKp 
on t is non-linear, and given that this is a peculiar change in unit of measure: 
T  (K) = t (±C) + 300 , this is not impossible from a strictly mathematical 
point of view. Predicted logKp values from Equation 6-2 vs experimental 
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logKp values are graphically represented in Figure 6-1. Leaving out the value 
for Oubain (experimental logKp = -9.67), we get r2 = 0.77, q2 = 0.75. 
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Figure 6-1. Predicted logKp values from Eq. 7-2 vs experimental logKp values from the 
common set between Flynn's and the Fully Validated sets. 
 
Results improve to r2 = 0.80, q2 = 0.74 if pH corrected values from the 
Fully validated set are used. If Molecular Volume (MV), as calculated at the 
water/bilayer interface during MD simulations, replaces Molecular Weight 
(MW), we get another improvement: 
 
logKp (cm/s) = -5.88 + 0.71 log Ko/w - 0.245 MV/t Equation 6-3 
 r
2
 = 0.81, q2 = 0.76, n = 80 
 
Predicted logKp values from Equation 6-3 vs experimental logKp values 
are graphically represented in Figure 6-2.  
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Validation of Eq. 6-3 brings to the results listed in Table 6-1. Equation 3 
gives better results than all the equations considered in the previous chapter. 
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Figure 6-2.  Predicted logKp values from Eq. 7-3 vs experimental logKp values from the 
common set between Flynn's and the Fully Validated sets. 
 
 
 
r2  
training set 
Adjusted r2 
training set 
r2 
test set 
Std. Dev. of Errors 
training set 
Eq. 6-3 
(n = 80) 0,82≤0,03 0,80≤0,04 0,82≤0,05 0,51≤0,06 
 
Table 6-1. Model validation for Eq. 7-3. Dimension of the test set = 27. Dimension of the 
training set = 53. Validation performed on 20 tests. 
 
From the considerations on the confidence interval of the correlation 
coefficient r made in Appendix A, we are clearly reaching the limits of a 
significant r2 value for n = 80, even with a very limited use of Molecular 
Dynamics (calculation of the Molecular Volume at the water/bilayer 
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interface). Applying Eq. 6-2 and Eq. 6-3, as well as a Potts & Guy type 
equation to a larger set would be essential to reduce the probability of 
overfitting and to reduce the confidence interval of correlation coefficient r, 
thus improving the significance of the calculated r2 value. The role of 
Molecular Dynamics simulations clearly seems more oriented to understand 
the mechanics of skin permeation, more than to develop improved predictive 
equations. Though, the capability of MD to directly calculate quantities of 
physical significance, forms a protection from theoretical artifacts and from 
data overfitting. 
 
 
Figure 6-3. Regions 1, 3 and 5 as defined in Table 5-3 (semi-transparent plane). Yellow line 
represents depht z = 0. 
 
6.2 Results from MD simulations 
 
Even though results obtained with semiempirical equations are 
promising, they do not offer better insight into the mechanics of permeation 
the original Potts and Guy equation. Molecular Dynamics, on the other hand 
can help gain a better understanding of the process under study.  
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One way in which we exploited this characteristic of MD was to divide 
the lipid matrix model in 18 partially overlapping regions, to study the 
importance of any region in the explanation of experimental data variability. 
  
The model membrane was ideally subdivided into 18 regions along the z 
direction, i.e. the bilayer normal (Figures 6-3, 6-4). The thickness of every 
region had to be chosen as a compromise: a region should not be so large that 
calculated quantities (permeability and diffusion coefficients) vary 
significantly, but it should be large enough to allow for a significant diffusion 
coefficient to be calculated from the RMSD. A thickness of 4 Å was chosen 
somehow arbitrarily, based on those considerations. Since the simulations 
span, at least from z = 60 Å (measured from the membrane midplane) to z = 
20 Å, the correlations were performed on 4 Å frames starting from z = 58 Å, 
and sliding the frames by 2 Å at a time to z = 21 Å. 
 
 
 
Figure 6-4. Tridimensional view of the model membrane intersected by the plane defining 
regions. 
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6.2.1 Diffusion coefficients 
  
Both the diffusion coefficient in the xy plane, Dxy, and along the z axis, 
Dz , were tested, although the latter was affected by a high bias introduced by 
steering in the z-direction. Results confirmed that the values obtained for Dz 
from MSD calculations have little physical significance. Even if the SMD 
force is applied only in the z direction, it will also affect the calculation of the 
diffusion coefficient in the xy plane, since it will affect the linear momentum 
of the permeant and the frequency of collisions with SC molecules. Though 
not entirely unbiased, Dxy is less affected the by the forced movement in the z-
direction, and maintains a physical significance showing a better correlation 
coefficient than Dz  when applied to the reduced data set, at least in some 
regions (Table 6-2). It must be noted that the correlation coefficient is highly 
dependent on the region where the diffusion coefficient is calculated. 
 
Quantity Region r2 
log Dxy 3 0.20 
log Dxy 2 0.12 
log Dxy 5 0.11 
log Dxy 4 0.10 
log Dz 14 0.09 
 
Table 6-2. Contribution of log Dxy vs log Dz to the explanation of the variability of the 
common data set.  
 
 
 
 87 
6.2.2 Physicochemical properties 
 
The correlation of different physicochemical properties of the permeant, 
calculated in the different regions of the SC, with skin permeation have been 
explored. The analysis starts with virtual log P, as the partition coefficient, 
not surprisingly, plays a pivotal role in many predictive equations, starting 
from Potts and Guy's. 
 
6.2.2.1 Virtual log P 
 
The values of virtual log P have been calculated for the 80 compounds in 
the 18 regions of the stratum corneum, and then correlated to the permeability 
coefficient. The value of r2 for these correlations ranges from 0,52 to 0,53 in 
the 18 regions, and q2 is about 0,50. It is clear that the role of virtual log P is 
unaffected by the region in which it is calculated. 
 
Even if the above values confirm the importance of lipophilicity in the 
determination of skin permeability, and the suitability of the calculated 
virtual log P as a parameter to be used in predictive equations, the r2 and q2 
values obtained above are too low for expecting a predictive value of this 
quantity alone. So a predictive equation of the form of Potts and Guy's, with 
or without temperature correction has been explored. The best equations 
turned out to be: 
 
pKp = 3.26 - 0.63 virtual log P + 0.0026 MW Equation 6-4  
r
2
= 0.61 q2= 0.59 
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without temperature correction, and 
 
pKp = 2.97 - 0.63 virtual log P + 0.11 MW/t Equation 6-5 
r
2
= 0.68 q2= 0.65 
 
with temperature correction.  
 
Both equations bring inferior results to their counterpart using 
experimental log P values. As we will show in Paragraph 6.3, the predictive 
power of virtual log P will be fully exploited only when it is paired with the 
diffusion coefficient.  
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6.2.3 Other physicochemical properties 
 
Physicochemical properties different from the virtual log P bring no 
improvement to the correlation, when used in isolation. Some of them like 
molecular weight or molecular volume greatly improve the predictive power 
of equations when paired to the virtual log P, but are of little value when used 
alone. The results obtained correlating the different molecular properties in 
the 18 different regions of the lipid matrix model are presented here. Results 
are shown in Table 6-3. 
 
Property Region r2 
PSA any 0.43 
Estimated frontal area 2,3 0.32 
MW any 0.27 
Molecular volume any 0.26 
Lipole (Broto & Moreau) 8,9 0.26 
Ovality any 0,16 
 
Table 6-6-3. Contribution of different molecular properties to the explanation of the 
variability of the common data set.  
 
 
6.2.4 Scoring functions 
  
The approach of evaluating the SC-permeant interaction energy through 
a scoring function brought interesting results, similar, in the case of MLPIns to 
the results obtained through the use of Virtual log P, not surprisingly. Of the 
five scoring functions, only CHARMM brought clearly inferior results, with 
MLP scoring functions bringing the best correlations, in particular at the 
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water/SC interface (Region 2) in the order MLPInSF > MLPInS3 > MLPInS2 > 
MLPInS (Table 6-3). 
 
 
Scoring function SC region r2 
MLPInSF 2 0.59 
MLPInS3 2 0.56 
MLPInS2 2 0.53 
MLPInS 2 0.51 
MLPInS2 3 0.51 
MLPInS 3 0.50 
MLPInS3 3 0.50 
MLPInSF 3 0.46 
CHARMM            2 0.18 
 
Table 6-6-4. SC-permeant Interaction Score in different regions of the SC. 
 
 
6.3 Predictive equations based on MD 
         
 Running the correlation analysis using the data from the reduced set 
(n = 80), the best equation obtained of the form: 
 
 
 
 is: 
 
)/log(30.044.1 333 ZoneZoneZone MVDPpKp −=  Equation 6-6 
           
)βlog(PD/MVαpK p +=
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r
2
 values for all the considered regions are shown in Table 6-5. Even 
considering the uncertainty on r2 from Table 6-5, the obtained results show 
that calculations performed in region 3 (the region at the water/bilayer 
interface) can explain 70% of the variance in pKp values, even using a non-
optimized equation. Calculations on region 2 (which is overlapping) give 
similar results, while r2 decreases rapidly for other regions, with minima at 9, 
14, 16 regions. These results suggest that the water/bilayer interface is the 
primary target to be taken into consideration when studying the behaviour of 
penetrants. 
 
A comparison with Potts & Guy on the same set (r2 = 0.66), shows that 
Equation 5-1, does not represent such a significant improvement to justify the 
use of MD simulations. Its importance lies mostly in highlighting that there 
are regions where the correlation is clearly superior to that of neighbouring 
(and even overlapping) regions, a remarkable result. So if regions 2 and 3 
seems to bring similar results, the correlation clearly drops in region 4, and 
subsequent regions. 
To conclude, though, that the region at the water/SC interface plays a 
major role in determining skin permeation would be erroneous. The result is 
equally likely to emerge from the limits of the method employed. The best 
results are originating from the first part of the simulation, when the 
trajectories from different simulations are better correlated to one another 
then at the end of the simulation. It must be noted, however, that the first 
Region 1 (water) does not correspond to the beginning of the simulations. At 
the beginning of the simulation, the center of mass of the permeant is 
positioned at z = 69 Å, but the first 10 Å of erratic movement of the permeant 
in water are omitted from the analysis. At the end of this 10 Å walk, the 
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trajectories from different simulation already show a degree of divergence 
(see Appendix D). 
 
 
Region Region position (Å) r2  Region Region position (Å) r2 
1 59-55 0.64  10 41-37 0.53 
2 57-53 0.69  11 39-35 0.58 
3 55-51 0.71 
 12 37-33 0.59 
4 53-49 0.61  13 35-31 0.56 
5 51-47 0.62  14 33-29 0.48 
6 49-45 0.58  15 31-27 0.53 
7 47-43 0.55  16 29-25 0.47 
8 45-41 0.54  17 27-23 0.54 
9 43-39 0.47  18 25-21 0.51 
 
Table 6-5. r2 values obtained running the regression analysis on 18 different regions of the in 
silico membrane. 
 
 
An improvement on Equation 6-6 can be obtained introducing a 
temperature related term, to account for the different temperatures at which 
experimental measurements of Kp were performed.  
 
  
One of the advantages of Molecular Dynamics is also the possibility of 
performing the simulations at the same temperature as the experiment. This 
procedure has been avoided so far due to the added computational cost of 
equilibrating the membrane at different temperatures, but it will be explored 
in the near future. 
 
The dependence of the diffusion coefficient D on absolute temperature T, 
for small molecules in rubbery polymers, can be expressed as [81]: 
 
 93 
TMVeDD /0
γ−
=
 
 
where D0 is a constant for a given molecule, MV is the molecular volume 
and γ is a constant. In logarithm form: 
 
TMVDD /loglog 0 γ−=  
 
 
So, as already pointed out by Vecchia and Bunge [81] a term 
proportional to MV/T (or MW/T where MW is molecular weight) can be 
used as a temperature correction factor. In our case, the simulations were 
performed at 300K, and the ratio between DT and D0, the diffusion coefficient 
at temperature T and 300K, respectively is: 
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So the term log(PDT) can be expressed as: 
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Equation 6-6 becomes: 
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where P, D300 and MV are calculated in region 3 (Figure 6-5). 
 
 
 
r2 
training set 
Adjusted r2 
training set 
r2 
test set 
Std Dev of 
Errors 
training set 
Potts & Guy 
(n = 80) 0,69≤0,03 0,66≤0,04 0,71≤0,06 0,66≤0,05 
Vecchia & Bunge 
(n = 80) 0,69≤0,02 0,67≤0,02 0,73≤0,06 0,65≤0,04 
Equation 6-6  
(n = 80) 0,70≤0,05 0,68≤0,05 0,72≤0,09 0,64≤0,05 
Equation 6-7 
(n = 80) 0,79≤0,03 0,77≤0,04 0,75≤0,08 0,56≤0,04 
 
Table 6-6. Model validation for both equations. Dimension of the test set = 27. Dimension of 
the training set = 53. Validation performed on 20 tests. 
 
 
 
Figure 6-5.Predicted logKp values from Eq. 6-7 vs experimental logKp values from the 
common set between Flynn's and the Fully Validated sets. Pink dots represent pKp values 
determined at 310K. Blue dots represent pKp values determined around 300K (see Appendix 
A). 
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Results for region 3 are shown in Table 6-6, as compared with the Potts 
& Guy model and the Vecchia & Bunge equation of the form: 
  
logMW/Tc'logPb'a'logkp ++=
 
 
Temperature correction to the Potts & Guy equation in the form MW/T 
brings no significant improvement when regression analysis is performed on 
the FV set. Temperature correction to Equation 6-6 brings a significant 
improvement on the training set r2, adjusted r2 and standard deviation of the 
errors, at the expense of adding one degree of freedom, but a more limited 
improvement to the r2 of the test set. 
 
To further assess the predictive power of the equation devised in this 
chapter, the cross-correlation between the different quantities has been 
considered. A cross-correlation matrix for key values used in the equations is 
shown in table 6-7. Though some of quantities obviously show a high 
correlation, quantities appearing in the same equation always have a low 
correlation, the highest value being r2 = 0.14 between log(PD)_Region 3 and 
log MV (also evaluated in Region 3) 
 
 
Virtual log P Log Dxy Region 3 Log P*Dxy Region 3 MW logMV 
Virtual log P 1     
Log Dxy zone 3 < 0.001 1    
Log P*Dxy zone 3 0.80 0.21 1   
MW 0.03 0.20 0.23 1  
logMV < 0.001 0.26 0.14 0.91 1 
 
Tabella 6-7. Cross correlation matrix for quantities appearing in the equations devised in this 
chapter. Listed are r2 values for any pair. 
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Conclusions 
 
Molecular Dynamics is now an established tool providing information on 
the possible impact of chemical modifications on skin penetration by a given 
compound. The availability of such a tool, in conjunction with existing 
mathematical models of skin permeability, can help rationalize the design of 
new drugs to manage cutaneous pathologies, as well as the lead optimization 
of a molecule to be administrated by transdermal route.  
  
Although Molecular Dynamics does not yet allow the spontaneous 
permeation of a solute through a membrane to be observed, its characteristics 
seem to complement existing macroscopic models. For example, the 
parameters obtained from simulations naturally take into account the 
anisotropy and non-homogeneity of biomembranes.  
 
One of the strengths of MD is that, when the simulations are well 
planned, it may represent a "statistical mechanics laboratory", and the 
analysis of MD trajectories can employ the results from statistical mechanics 
to calculate relevant quantities. Steered Molecular Dynamics (SMD), in 
particular, truly is applied Non Equilibrium Statistical Mechanics (NESM), a 
field that gained momentum in the last decades, with the development of 
fluctuation-dissipation relations, and other important results, such as 
Jarzinsky equality. The two fields of SMD and NESM complement each 
other well and are destined to bring other exciting developments.  
 
On the other hand, one of the difficulties in obtaining meaningful results 
with numerical simulations, as opposed to a purely theoretical approach, lies 
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in the complexity of planning the in silico experiments, including the choice 
of simulation parameters. This is particularly true in the case of the screening 
of a large number of systems: weaknesses in the experimental design often 
become apparent only after doing a great amount of calculations, and force 
the in silico experimenter to make corrections to the protocol and start again. 
 
In this work, after building a stable and equilibrated model for the 
stratum corneum (SC) lipid bilayer, SMD simulations were performed to 
study the penetration of 80 permeants of known permeability coefficient 
through the SC. MD has been utilized before by other Authors for studying 
permeation of chemicals through plasma membranes, notably the work by 
Marrink and Berendsen, whose approach was later applied to the SC by Das, 
Noro and Olmsted. A screening of a large number of molecules with MD 
simulations, though has never been attempted to our knowledge. The goal 
was to assess the possibility of using MD to assist in the development of 
predictive equations of skin permeability, more than gaining new insight in 
the mechanics of SC permeation. The approach developed (for plasma 
membranes) by Marrink and Berendsen for the prediction of permeability 
couldn't be applied, though, because of the unfeasibility of Free Energy 
calculations from SMD simulations in the screening of 80 permeants, due to 
the large amount of trajectories required. 
 
Instead, SMD has been used in an indirect way as a mean to explore the 
conformational and property space of the permeants in the different 
microenvironments of the stratum corneum. SMD was also used in a direct 
way to calculate averaged diffusion coefficients in different regions of the 
stratum corneum. What proved to be the best option, was a mixed approach 
where the averaged diffusion coefficients in the plane parallel to the bilayer 
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surface were calculated in different regions of the SC, and then used together 
with the physicochemical properties in the correlation equation. 
 
This approach has allowed us to correlate the permeability coefficient to 
averaged physicochemical properties, improving on existing semi-empirical 
methods (employing the same quantities determined experimentally). The 
obtained equation compares well with the Potts and Guy equation. Further 
improvement of the correlation coefficient seems difficult, considering the 
heterogeneity of the experimental data sets and the experimental error 
involved in the measurement of the permeability coefficient. 
  
Further study of SMD data may still allow us to gain a better 
understanding of the physical process. Performing multiple SMD simulations 
for a small number of permeants, or designing a new protocol using only 
equilibrium simulations in specific regions of the lipid matrix model, will 
allow us to make free energy calculations. So, the work done here is just a 
first step in the direction of actually employing Molecular Dynamics in 
developing viable predictive equations of skin permeability.  
 
As a final point, our work has shown that, as stated above, the 
uncertainty of experimental values of the permeability coefficient is too high 
to expect significant improvements in the predictive power of equations. The 
Fully Validated set represents a great advance in reducing the bias of Flynn's 
set and making the variability of experimental conditions explicit. We feel, 
though, that this is not enough. As an effect of Regulation (EC) No 
1223/2009 on cosmetic products, testing of finished cosmetic products and 
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ingredients on animals is prohibited in the European Union, as well as the 
marketing of cosmetic products which have been tested on animals. If 
governmental Authorities feel that the development of alternative methods to 
in vivo and in vitro assays for the determination of skin permeability to 
chemical compounds is worth consideration and funding, then developing a 
research project for measuring skin permeability coefficients of a large set of 
molecules in controlled and reproducible conditions would be an important 
step in the right direction. 
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 Appendix A. The reduced data set 
  
 
The reduced data set (Table A.1) is the intersection of Flynn's set and the 
Vecchia and Bunge's Fully Validated set. It is comprised of 80 compounds, 
and it is used in this work to eliminate non validated data (according to the 
five validation criteria exposed below) from Flynn's set, while retaining the 
ability to compare results with methods optimized on Flynn's set. 
 
Fully validated set validation criteria.  
"Data in the FV database were required to meet five criteria: 
(a) the temperature must be known and be between 20 and 40 ±C, 
(b) more than 10% of the penetrating compound must be in nonionized form, 
(c) a valid log Kow (Editor's note: octanol/water partition coefficient, logP in 
this work) [...] must represent the the penetrating molecule (usually the 
nonionized compound), 
(d) the measurement must have been determined at a steady state, 
(e) the donor and receptor fluid do not compromise (more than water does) 
the barrier of the skin. Steady-state permeability coefficients require either 
constant vehicle concentration and sink conditions in the receptor or 
adjustment of the data to account for changing vehicle and/or receptor 
concentrations" [81]. 
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Name Mass pKp LogP T (K) t (∞C) 
2,3-butanediol 90.12 4.4 -0.92 303 30 
2,4,6-trichlorophenol 197.45 1.23 3.69 298 25 
2,4-dichlorophenol 163 1.22 3.08 298 25 
2-butanone 72.11 2.35 0.28 303 30 
2-chlorophenol 128.56 1.48 2.15 298 25 
2-naphtol 144.17 1.55 2.84 298 25 
3,4-xylenol 122.16 1.44 2.35 298 25 
3-nitrophenol 139.11 2.25 2 298 25 
4-bromophenol 173.01 1.44 2.59 298 25 
4-chlorophenol 128.56 1.26 2.39 298 25 
4-choro-m-cresol? 142.58 1.44 3.1 298 25 
4-ethylphenol 122.16 1.46 2.4 298 25 
4-nitrophenol 139.11 2.25 1.96 298 25 
aldosterone 360.44 5.52 1.08 299 26 
amobarbital 226.27 2.64 1.96 303 30 
atropine 289.37 4.86 1.81 303 30 
barbital 184.19 3.95 0.65 303 30 
benzyl alcohol 108.13 2.22 1.1 298 25 
buatnoic acid 88.1 3 0.79 300 27 
butobarbital 212.25 3.72 1.65 303 30 
cellosolve (2-ethoxy ethanol) 90.12 3.6 -0.54 303 30 
chloroxylenol 156.61 1.23 3.39 298 25 
chlorpheniramine 274.79 2.64 3.38 303 30 
cortexolone 346.46 4.12 2.52 299 26 
cortexone (deoxycorticosterone) 330.46 3.35 2.88 299 26 
corticosterone 346.46 4.22 1.94 298 25 
cortisone 360.44 5 1.42 299 26 
diethylcarbamazine 199.29 3.89 0.1 303 30 
ephedrine 165.23 2.2 1.03 303 30 
estradiol 272.38 3.52 2.69 299 26 
estriol 288.38 4.4 2.47 299 26 
estrone 270.37 2.44 2.76 299 26 
ethanol 46.07 3.1 -0.31 298 25 
ethylether 74.12 1.8 0.83 303 30 
fentanyl 336.47 1.94 4.37 303 30 
heptanoic acid 130.18 1.7 2.5 300 27 
hexanoic acid 116.16 1.85 1.9 300 27 
hydrocortisone 362.46 5.52 1.53 299 26 
[hydrocortisone-21-yl] hemipimelate 504.61 2.64 3.26 310 37 
[hydrocortisone-21-yl] hemisuccinate 462.53 3.09 2.11 310 37 
[hydrocortisone-21-yl] hexanoate  460.6 1.74 4.48 310 37 
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Name Mass pKp LogP T (K) t (∞C) 
[hydrocortisone-21-yl]-hydroxy-hexanoate 476.6 3.04 2.79 310 37 
[hydrocortisone-21-yl]-N,N-dimethyl-succinamate 491.64 4.17 2.03 310 37 
[hydrocortisone-21-yl]-octanoate 488.66 1.21 5.49 310 37 
[hydrocortisone-21-yl]-pimelamate 519.67 3.05 2.31 310 37 
[hydrocortisone-21-yl]-propionate 418.52 2.47 3 310 37 
[hydrocortisone-21-yl]-succinamate 463.59 4.59 1.43 310 37 
hydroxyprogesterone 332.48 3.22 3.17 299 26 
isoquinoline 129.16 1.77 2.03 303 30 
m-cresol 108.14 1.82 1.96 298 25 
methanol 32.04 3.3 -0.77 303 30 
methyl-[hydrocortisone-21-yl]-pimelate 518.64 2.27 3.7 310 37 
methyl-[hydrocortisone-21-yl]-succinate 476.56 3.68 2.58 310 37 
methyl-4-hydroxybenzoate 152.15 2.04 1.96 298 25 
naproxen 230.26 3.12 3.18 310 37 
n-butanol 74.12 2.6 0.88 298 25 
n-decanol 158.28 1.1 4 298 25 
n-heptanol 116.2 1.46 2.72 298 25 
n-hexanol 102.17 1.89 2.03 298 25 
nicotine 162.23 1.7 1.17 303 30 
n-nonanol 144.25 1.22 3.62 298 25 
n-octanol 130.23 1.28 2.97 298 25 
n-pentanol 88.15 2.22 1.56 298 25 
n-propanol 60.1 2.85 0.25 298 25 
o-cresol 108.14 1.8 1.95 298 25 
octanoic acid 144.21 1.6 3 300 27 
ouabain 584.65 6.11 -2 303 30 
p-cresol 108.14 1.75 1.95 298 25 
pentanoic acid 102.13 2.7 1.3 300 27 
phenobarbital 232.24 3.35 1.47 303 30 
phenol 94.11 2.09 1.46 298 25 
pregnenolone 316.48 2.82 3.13 299 26 
progesterone 314.46 2.82 3.77 299 26 
resorcinol 110.11 3.62 0.8 298 25 
salicylic acid 138.12 1.89 2.26 303 30 
sufentanyl 386.55 1.9 4.59 310 37 
testosterone 288.42 3.4 3.31 299 26 
thymol 150.22 1.28 3.34 298 25 
 
Table A.1. The reduced data set. logKp is the logarithm of the permeation coefficient Kp, 
where Kp is expressed in cm/h. log P is the logarithm of the octanol/water partition 
coefficient. T and t are the experimental temperatures in K and ±C, respectively [81]. 
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Appendix B. Flynn's set 
 
 
 
Name Mass logKp (cm/h) logKp (cm/s) LogP 
2,3-butanediol 90.12 -4.40 -7.96 -0.92 
2,4,6-trichlorophenol 197.45 -1.23 -4.79 3.69 
2,4-dichlorophenol 163 -1.22 -4.78 3.08 
2-butanone 72.11 -2.35 -5.91 0.28 
2-chlorophenol 128.56 -1.48 -5.04 2.15 
2-naphtol 144.17 -1.55 -5.11 2.84 
3,4-xylenol 122.16 -1.44 -5.00 2.35 
3-nitrophenol 139.11 -2.25 -5.81 2.00 
4-bromophenol 173.01 -1.44 -5.00 2.59 
4-chlorophenol 128.56 -1.44 -5.00 2.39 
4-choro-m-cresol 142.58 -1.26 -4.82 3.10 
4-ethylphenol 122.16 -1.46 -5.02 2.40 
4-nitrophenol 139.11 -2.25 -5.81 1.96 
aldosterone 360.44 -5.52 -9.08 1.08 
amobarbital 226.27 -2.64 -6.20 1.96 
atropine 289.37 -5.07 -8.63 1.81 
barbital 184.19 -3.95 -7.51 0.65 
benzyl alcohol 108.13 -2.22 -5.78 1.10 
buatnoic acid 88.1 -3.00 -6.56 0.79 
butobarbital 212.25 -3.71 -7.27 1.65 
cellosolve (2-ethoxy ethanol) 90.12 -3.60 -7.16 -0.54 
chloroxylenol 156.61 -1.28 -4.84 3.39 
chlorpheniramine 274.79 -2.66 -6.22 3.38 
codeine 299.36 -4.31 -7.87 0.89 
cortexolone 346.46 -4.13 -7.69 2.52 
cortexone (deoxycorticosterone) 330.46 -3.35 -6.91 2.88 
corticosterone 346.46 -4.22 -7.78 1.94 
cortisone 360.44 -5.00 -8.56 1.42 
diethylcarbamazine 199.29 -3.89 -7.45 0.10 
digitoxin 764.94 -4.89 -8.45 1.86 
ephedrine 165.23 -2.22 -5.78 1.03 
estradiol (1) 272.38 -3.52 -7.08 2.69 
estradiol (2) 272.38 -2.28 -5.84 2.69 
estriol 288.38 -4.40 -7.96 2.47 
estrone 270.37 -2.44 -6.00 2.76 
ethanol 46.07 -3.10 -6.66 -0.31 
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Name Mass logKp (cm/h) logKp (cm/s) LogP 
ethylbenzene 106.17 0.08 -3.48 3.15 
ethylether 74.12 -1.80 -5.36 0.83 
etorphine 411.53 -2.44 -6.00 1.86 
fentanyl (1) 336.47 -2.25 -5.81 4.37 
fentanyl (2) 336.47 -2.00 -5.56 4.37 
fluocinonide 494.52 -2.77 -6.33 3.19 
heptanoic acid 130.18 -1.70 -5.26 2.50 
hexanoic acid 116.16 -1.85 -5.41 1.90 
hydrocortisone (1) 362.46 -5.52 -9.08 1.53 
hydrocortisone (2) 362.46 -3.93 -7.49 1.53 
[hydrocortisone-21-yl]-octanoate 488.66 -1.21 -4.77 5.49 
[hydrocortisone-21-yl]-propionate 418.52 -2.47 -6.03 3.00 
[hydrocortisone-21-yl] hemipimelate 504.61 -2.75 -6.31 3.26 
[hydrocortisone-21-yl] hemisuccinate 462.53 -3.20 -6.76 2.11 
[hydrocortisone-21-yl] hexanoate  460.6 -1.75 -5.31 4.48 
[hydrocortisone-21-yl]-hydroxy-hexanoate 476.6 -3.04 -6.60 2.79 
[hydrocortisone-21-yl]-N,N-dimethyl-succinamate 491.64 -4.17 -7.73 2.03 
[hydrocortisone-21-yl]-pimelamate 519.67 -3.05 -6.61 2.31 
[hydrocortisone-21-yl]-succinamate 463.59 -4.59 -8.15 1.43 
hydromorphone 285.3 -4.82 -8.38 1.25 
hydroxypregnenolone 332.48 -3.22 -6.78 3.00 
hydroxyprogesterone 332.48 -3.22 -6.78 2.74 
isoquinoline 129.16 -1.78 -5.34 2.03 
m-cresol 108.14 -1.82 -5.38 1.96 
meperidine 247.33 -2.43 -5.99 2.72 
methanol 32.04 -3.30 -6.86 -0.77 
methyl-[hydrocortisone-21-yl]-pimelate 518.64 -2.27 -5.83 3.70 
methyl-[hydrocortisone-21-yl]-succinate 476.56 -3.68 -7.24 2.58 
methyl-4-hydroxybenzoate 152.15 -2.04 -5.60 1.96 
morphine 285.34 -5.03 -8.59 0.62 
naproxen 230.26 -3.40 -6.96 3.18 
n-butanol 74.12 -2.60 -6.16 0.88 
n-decanol 158.28 -1.10 -4.66 4.00 
n-heptanol 116.2 -1.50 -5.06 2.72 
n-hexanol 102.17 -1.89 -5.45 2.03 
nicotine 162.23 -1.71 -5.27 1.17 
nitroglycerine 227.09 -1.96 -5.52 2.00 
N-nitrosodiethanolamine 134.13 -5.22 -8.78 -1.58 
n-nonanol 144.25 -1.22 -4.78 3.62 
n-octanol 130.23 -1.28 -4.84 2.97 
n-pentanol 88.15 -2.22 -5.78 1.56 
n-propanol 60.1 -2.85 -6.41 0.25 
o-cresol 108.14 -1.80 -5.36 1.95 
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Name Mass Log-Kp (cm/h) Log-Kp (cm/s) LogP 
octanoic acid 144.21 -1.60 -5.16 3.00 
ouabain 584.65 -6.11 -9.67 -2.00 
p-cresol 108.14 -1.75 -5.31 1.95 
pentanoic acid 102.13 -2.70 -6.26 1.30 
phenobarbital 232.24 -3.34 -6.90 1.47 
phenol 94.11 -2.09 -5.65 1.46 
pregnenolone 316.48 -2.82 -6.38 3.13 
progesterone 314.46 -2.82 -6.38 3.77 
resorcinol 110.11 -3.62 -7.18 0.80 
salicylic acid 138.12 -2.20 -5.76 2.26 
scopolamine 303.35 -4.30 -7.86 1.24 
styrene 104.15 -0.19 -3.75 2.95 
sucrose 342.3 -5.28 -8.84 -2.25 
sufentanyl 386.55 -1.92 -5.48 4.59 
testosterone 288.42 -3.40 -6.96 3.31 
thymol 150.22 -1.28 -4.84 3.34 
toluene 92.14 0.00 -3.56 2.75 
water 18.01 -3.30 -6.86 -1.38 
 
Table B.1. Flynn's data set. logKp (cm/h) is the logarithm of the permeation coefficient Kp, 
where Kp is expressed in cm/h. logKp (cm/s) is the logarithm of the permeation coefficient 
Kp, where Kp is expressed in cm/s. log P is the logarithm of the octanol/water partition 
coefficient (note the different notation with respect to Flynn's original publication) 
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Appendix C. Graphs and trajectories 
  
 
 x-y trajectories of the permeant's Center of Mass (COM) are 
represented here. Sparser region correspond to movement in water and at the 
water/SC interface, while denser regions correspond to deeper layers of the 
SC. x-y trajectories allow to follow the evolution of the simulation, in 
particular it allows to spot simulations where the permeant has crossed 
simulation box boundaries. 
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2-butanone 
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Figure C.1. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 
2-chlorophenol 
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Figure C.2. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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2-naphtol 
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Figure C.3. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 
3-nitrophenol 
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 Figure C.4. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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4-bromophenol 
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Figure C.5. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.6. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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4-chlorophenol 
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 Figure C.7. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.8. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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4-nitrophenol 
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Figure C.9. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.10. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Amobarbital 
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Figure C.11. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.12. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 116 
Barbital 
 
0
5
10
15
20
25
30
-7 -6 -5 -4 -3 -2 -1 0 1 2
x (A)
y 
(A
)
 
 
 Figure C.13. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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 Figure C.14. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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2,3-butanediol 
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Figure C.15. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.16. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Butobarbital 
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Figure C.17. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.18. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 119 
Chloroxylenol 
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Figure C.19. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.20. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Cortexolone 
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 Figure C.21. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.22. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Corticosterone 
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Figure C.23. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.24. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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2,4-dichlorophenol 
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Figure C.25. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.26. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Ephedrine 
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Figure C.27. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.28. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Estriol 
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Figure C.29. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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 Figure C.30. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Ethanol 
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Figure C.31. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.32. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Fentanyl 
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Figure C.33. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 
[hydrocortisone-21-yl]-hemipimelate 
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Figure C.34. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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[hydrocortisone-21-yl]-hemisuccinate 
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Figure C.35. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.36. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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[hydrocortisone-21-yl]-hydroxy-hexanoate 
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Figure C.37. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 
[hydrocortisone-21-yl]-N,N-dimethylsuccinamate 
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Figure C.38. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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[hydrocortisone-21-yl]-octanoate 
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Figure C.39. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.40. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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[hydrocortisone-21-yl]-propionate 
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Figure C.41. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.42. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Heptaonic acid 
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Figure C.43. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.44. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Hydrocortisone 
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Figure C.45. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.46. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Hydroxyprogesterone 
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Figure C.47. x(Å) vs y(Å) coordinate of permeant's center of mass. 
Isoquinoline 
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Figure C.48. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 134 
m-Cresol 
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Figure C.49. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.50. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Methyl-4-hydroxybenzoate 
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Figure C.51. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 
Methyl-[hydrocortisone-21-yl]-pimelate 
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Figure C.52. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Methyl-[hydrocortisone-21-yl]-succinate 
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Figure C.53. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.54. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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n-Butanol 
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Figure C.55. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.56. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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n-Heptanol 
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Figure C.57. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 
n-Hexanol 
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Figure C.58. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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n-Nonanol 
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Figure C.59. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.60. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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n-Pentanol 
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Figure C.61. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.62. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Nicotine 
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Figure C.63. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.64. x(Å) vs y(Å) coordinate of permeant's center of mass. 
 142 
Octaonic acid 
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Figure C.65. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.66. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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p-Cresol 
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Figure C.67. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.68. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.69. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.70. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.71. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.72. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.73. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.74. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.75. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.76. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.77. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.78. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.79. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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Figure C.80. x(Å) vs y(Å) coordinate of permeant's center of mass. 
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